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Summary 
Repeat proteins are ubiquitous and are involved in many biological reactions. They have non-
globular structures acting as scaffolds for protein–protein interactions. A repeat protein is 
composed of tandem repeats of a basic structural motif of 20–40 amino acids. It is mainly 
stabilized by hydrophobic interactions within the single repeats and between adjacent repeats. 
Long-range tertiary contacts, which are the hallmark of globular proteins, are very rare in repeat 
proteins. The modular structure poses exigent questions about the folding of repeat proteins. 
Does the modular nature affect the folding mechanism? Do the repeating motifs fold 
independently, leading to tangible folding intermediates? To explore the folding properties of 
repeat proteins, we selected an ankyrin repeat protein and a cysteine-rich repeat protein from 
Helicobacter pylori. The ankyrin motif has 33 residues arranged in a β-turn followed by two α-
helices connected by a loop. The cysteine-rich motif has 36 residues arranged in two α-helices 
connected by a disulfide bridge.   
The ankyrin repeat protein was selected from a consensus library of ankyrins with only a single 
repeat flanked by N- and C-terminal capping repeats. I found that this simplest possible ankyrin 
repeat folds in a two-state manner at 5 °C, similar to many small globular proteins. However, 
folding is more complex at 25 °C and above where equilibrium intermediates are observed. The 
results are described in Chapter 2 and are based on thermal melting and urea-induced unfolding 
studies (both kinetic and equilibrium) and on differential scanning calorimetry (DSC).  
A family of cysteine-rich repeat proteins (Hcp) was found in Helicobacter pylori, a major risk 
factor for several gastric diseases. A single disulfide bridge within each repeat is a unique feature 
of this class of repeat proteins. I have studied the folding of the protein HcpB with four repeats 
and four consecutive disulfide bridges. The results are described in Chapter 3. The disulfide 
bridges of HcpB are arranged one after the other along the amino acid sequence of HcpB, an 
arrangement well suited to demonstrate independent folding of the four repeats within HcpB. 
From studies on disulfide-containing globular proteins we know that wrong, that is, non-native 
disulfide bridges can form during folding and have to be re-arranged in order to reach the native 
disulfide pattern. In the case of a repeat protein, wrong disulfide bonds should not appear if the 
repeats fold in an independent way before disulfide formation. I have followed in vivo oxidative 
folding of HcpB in the periplasm of E. coli, which has an enzyme system for disulfide formation 
(DsbA/DsbB) and another one for re-arranging wrong disulfide bonds (DsbC/DsbD). I find that 
the folding of HcpB needs only DsbA/DsbB. Hence, no wrong disulfide bonds are formed during 
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the folding of HcpB in the periplasm of E. coli. Obviously, a repeat-like folding pattern develops 
before disulfide formation, circumventing wrong disulfide formation. 
Folding of HcpB in the test tube was followed in the presence of a glutathione redox buffer. Here 
again, no wrong disulfide formation is seen. The result is based on mass-spectrometric analysis of 
folding intermediates with one, two and three disulfide bonds. Folding proceeds through one 
major folding intermediate with three native disulfide bonds in repeats 2, 3 and 4 and a reduced 
pair of cysteines in repeat 1. Establishment of the disulfide bond in repeat 1 limits the overall 
folding rate of HcpB and contributes almost half of the thermodynamic stability of HcpB. Taken 
together the results described in Chapters 2 and 3 provide a first glimpse on how unfolded 
polypeptide chains fold into the modular structure of repeat proteins. 
In Chapter 4, I describe experiments on the effect of urea and guanidinium chloride (GdmCl) on 
the stability of a leucine zipper (coiled coil). The free energy of proteins can be deduced from the 
effect of chemical denaturants on protein stability. Data analysis follows the linear extrapolation 
model (LEM). Occasionally, LEM provides different values of stability depending on the nature 
of the chemical denatured used. I have tried to solve this problem on the example of leucine 
zipper ABSS designed in our laboratory. This two-stranded leucine zipper features several 
electrostatic interactions between charged amino acid side chains and provides a good model to 
study the effect of urea and GdmCl, the two most widely used denaturants, on protein 
electrostatics. Previously, we had shown that GdmCl unfolding leads to a higher free energy of 
unfolding of ABSS at pH 2 than unfolding with urea. To clarify this puzzling observation, the 
kinetics of folding of ABSS was measured in the presence of urea and GdmCl at pH 2 and pH 7. 
The apparent higher stability deduced from GdmCl unfolding at low pH can be plausibly 
explained by a thousand-fold slower rate of unfolding, indicating strong charge screening of 
unfavorable charge-charge repulsions at pH 2 by GdmCl but not by urea.  
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Zusammenfassung 
Repeat Proteine sind weit verbreitet und an vielen biologischen Reaktionen beteiligt. Sie besitzen 
typischerweise eine nicht-globuläre Struktur und wirken als Gerüste für Protein-Protein 
Wechselwirkungen. Ein Repeat Protein besteht aus aneinander gereihten, sich repetierenden 
Motiven („Repeats“), die je 20–40 Aminosäurereste enthalten. Die Moleküle werden vorwiegend 
durch hydrophobe Kräfte innerhalb der einzelnen Repeats und zwischen benachbarten Repeats 
stabilisiert. Kontakte zwischen weit auseinander liegenden Sequenzabschnitten, wie sie für 
globuläre Proteine typisch sind, kommen in Repeat Proteinen selten vor. Aus der modularen 
Struktur ergeben sich Fragen zum Faltungsmechanismus. Wie beeinflusst die modulare Struktur 
den Faltungsmechanismus? Falten sich die Repeats unabhängig voneinander, was zu fassbaren 
Zwischenprodukten führen dürfte? Um die Faltung von Repeat Proteinen zu erforschen, haben 
wir ein Ankyrin Repeat Protein und ein Cystein-reiches Repeat Protein aus Helicobacter pylori 
untersucht. Das Ankyrinmotiv besteht aus 33 Resten, die in einer β-Schleife gefolgt von zwei 
über einen Loop verbundene α-Helices angeordnet sind. Das Motiv des Cystein-reichen Repeats 
hat 36 Reste und besteht aus zwei Disulfid-verknüpften α-Helices.  
Das Ankyrin Repeat Protein wurde aus einer Konsens-Bibliothek ausgewählt, die Ankyrine mit 
einem einzigen Repeat zwischen N- und C-terminalen „Repeat-Kappen“ (capping repeats) enthält. 
Dieses einfachste Ankyrin faltet bei 5 °C nach einem einfachen 2-Zustandsmechanismus, ganz 
ähnlich wie viele kleine, globuläre Proteine. Allerdings ist der Faltungsmechanismus bei 25 °C 
und darüber komplizierter, denn bei höherer Temperatur werden Faltungsintermediate beobachtet. 
Die Resultate sind im Kapitel 2 beschrieben. Sie basieren auf thermischer und chemischer 
Denaturierung (kinetisch und Gleichgewichtsmessungen) und auf differentieller Scanning-
Kalorimetrie (DSC).  
Eine Familie von Cystein-reichen Repeat Proteinen (Hcp) wurde in Helicobacter pylori, einem 
Risikofaktor für Erkrankungen des Magens, gefunden. Eine einzelne Disulfidbrücke in jedem 
Repeat ist ein besonderes Merkmal dieser Proteinklasse. Ich habe die Faltung von HcpB, einem 
Protein mit vier Repeats und vier Disulfidbrücken, untersucht. Die Resultate sind im Kapitel 3 
beschrieben. Die Disulfidbrücken von HcpB erscheinen der Reihe nach in der 
Aminosäurensequenz. Aus der Untersuchung von globulären, disulfidhaltigen Proteinen ist 
bekannt, dass im Laufe der Faltung falsche, d. h. nicht-native Disulfidbrücken entstehen, die zur 
Erlangung des nativen Disulfidmusters nachträglich umgeordnet werden müssen. Bei der Faltung 
von Repeat Proteien, die in jedem Repeat eine Disulfidbrücke aufweisen, sollten keine nicht-
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nativen Disulfidbrücken entstehen, vorausgesetzt die Repeats entstehen unabhängig voneinander 
und vor der Disulfidbildung. Ich habe die oxidative Faltung von HcpB in vivo im Periplasma von 
E. coli untersucht. Das Bakterium besitzt ein Enzymssystem zur Bildung von Disulfidbindungen 
(DsbA/DsbB) und eines für das Umordnen falscher Disulfidbindungen (DsbC/DsbD). Die 
Faltung von HcpB benötigt nur das System DsbA/DsbB. Demzufolge entstehen während der 
Faltung von HcpB im Periplasma keine falschen Disulfidbindungen. Offensichtlich entsteht ein 
repetitives Strukturmuster schon vor den Disulfidbindungen.  
Die Faltung von HcpB im Reagensglas untersuchte ich in Gegenwart von Glutathion-
Redoxpuffer. Auch hier entstehen keine falschen Disulfidbindungen. Das Resultat wurde mit 
Hilfe der massenspektrometrischen Analyse von Faltungsintermediaten mit einer, zwei und drei 
Disulfidbindungen erhoben. Die Faltung erfolgt über ein Hauptzwischenprodukt, das in den 
Repeats 2, 3 und 4 native Disulfidbindungen und in Repeat 1 zwei reduzierte Cysteine enthält. 
Die Bildung der Disulfidbindung im 1. Repeat bestimmt die Faltungsgeschwindigkeit des 
gesamten Proteins und trägt beinahe die Hälfte der Stabilität von HcpB bei. Die Resultate in den 
Kapiteln 2 und 3 geben einen ersten Einblick in die Art und Weise, wie sich ungefaltete 
Polypeptidketten zu modularen Strukturen in Repeat Proteinen auffalten können.  
Im Kapitel 4 beschreibe ich Experimente zum Einfluss von Harnstoff und Guanidiniumchlorid 
(GdmCl) auf die Stabilität eines Leuzin-Zippers (Coiled Coil). Die freie Enthalpie von Proteinen 
lässt sich aus dem Einfluss von chemischen Denaturantien auf die Proteinstabilität herleiten. Die 
Datenanalyse geschieht nach dem Modell der linearen Extrapolation (LEM). Allerdings kommt 
es vor, dass die linear Extrapolation für verschiedene Denaturantien verschiedene Stabilitätswerte 
ergibt. Ich habe versucht, dieses Problem für den Leuzin-Zipper ABSS, einem Proteindesign aus 
unserer Arbeitsgruppe, zu lösen. Der zweisträngige Leuzin-Zipper zeigt mehrere elektrostatische 
Wechselwirkungen zwischen geladenen Aminosäureseitenketten. Er ist deshalb ein gutes Modell, 
um den Einfluss der beiden häufig verwendeten Denaturantien Harnstoff und GdmCl auf die 
Proteinelektrostatik zu studieren. Wir hatten zuvor gezeigt, dass bei pH 2 die GdmCl-
Denaturierung eine grössere Stabilität als die Harnstoff-Denaturierung ergibt. Um diesen 
rätselhaften Befund zu erklären, wurde die Faltungskinetik von ABSS in Gegenwart von Harnstoff 
und GdmCl bei pH 2 und pH 7 gemessen. Die aus der GdmCl-Denaturierung abgeleitete höhere 
Stabilität kann mit der tausendfach langsameren Denaturierungsgeschwindigkeit in Gegenwart 
von GdmCl bei pH 2 plausibel erklärt werden. GdmCl, nicht aber Harnstoff, dämpft energetisch 
ungünstige Ladungsabstossungen bei pH 2 und erhöht dadurch die Stabilität von ABSS im sauren 
pH-Bereich.  
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1 Protein Folding and Repeat Proteins 
1.1 Protein folding 
Understanding protein folding means understanding the molecular processes by which the one-
dimensional sequence information of a polypeptide chain is transformed into the three-
dimensional structure of a biologically active protein. This is a topic of tremendous biological 
importance and intellectual interest [1-3]. Significant advances have been made over the years, 
ranging from Anfinsen’s original work on ribonuclease to the “new view” of protein folding 
describing the process as a summation of multiple microscopic pathways on an energy landscape. 
Folding can be studied in vitro and important advances have evolved from experimentation under 
artificial conditions outside of the living cell. Sections 1.1.1 to 1.1.4 give a brief historical 
summary. In nature, most of protein folding is an intracellular process, which may be very 
different from protein folding in the test tube. As a result, in vivo studies have matured in parallel 
to the in vitro folding studies (section 1.2).   
Understanding protein folding has practical applications in medicine and biotechnology. 
Expression of recombinant proteins is often hampered by low yields, misfolding and aggregation. 
Here, a deeper understanding of protein folding could be beneficial. Also, misfolding and 
aggregation of proteins plays a role in the development of several pathologies of which BSE and 
Alzheimer’s disease are prominent examples [4].  
1.1.1 The beginnings 
Around 1930, at a time when proteins were mainly envisioned as gelatinous matter without 
defined molecular structure, the first studies on protein denaturation and on the recovery of the 
native state appeared in the literature [5]. Several papers were published in the 1930’s 
demonstrating reversibility of protein unfolding. This has led to the concept that protein folding 
is a spontaneous process. In the 1950’s, new thermodynamic insight underlined the importance of 
non-covalent interactions in proteins. An important concept arose in 1959 when Kauzmann 
suggested that the hydrophobic effect is the driving force directing the folding process [6]. 
Starting in the 1960’s, the determination of the 3D structure of proteins by X-ray diffraction 
provided a new basis for structure analysis and for studying the folding process [7].  
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The Anfinsen postulate – In 1961 Anfinsen and his co-workers published a seminal paper on the 
spontaneous oxidative refolding of reduced and unfolded ribonuclease into active enzyme. This 
marked the beginning of modern research into protein folding. Anfinsen’s conclusion was 
succinct: “All the information necessary to achieve the native conformation of a protein in a 
given environment is contained in its amino acid sequence” [8]. The corollary of this postulate is 
the thermodynamic control of protein folding, meaning that the native conformation is at the 
minimum of the Gibbs free energy.  
The Levinthal paradox – Cyrus Levinthal invoked an influential argument in 1968 that came to 
be known as Levinthal’s paradox, stating that due to the vast number of conformations a 
polypeptide can adopt, it will not fold in a reasonable amount of time if it has to randomly search 
the entire conformational space [9]. To resolve the paradox it was assumed that proteins travel 
only a limited subset of conformations or that folding proceeds along a unique and well-defined 
folding pathway, akin to a chemical reaction pathway between small molecules. Levinthal and 
later Wetlaufer [10] have regarded protein folding to be under kinetic rather than thermodynamic 
control. Kinetic control means that folding is rapid (seconds) because it is pathway dependent, 
that is, the final structure may depend on the denatured state from where folding is initiated. 
Hence, the folded protein may occupy some local energy minimum instead of the global 
minimum. In contrast, thermodynamic control implies that a folding protein is at its global energy 
minimum and that, therefore, folding has to be pathway-independent and the native structure 
depends on final conditions, not on the conditions from where folding starts. Time is not relevant 
in thermodynamically controlled folding and it may take long before the global energy minimum 
is reached through an extensive conformational search.  
Levinthal’s paradox has been likened to a ball rolling on an entirely ‘flat playing field’ or ‘golf-
course‘ before dropping to the bottom of a single, small hole representing the global energy 
minimum of the native state [11] (Fig. 1.1).  
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Figure 1.1. The Levinthal 'golf-course' 
landscape. N is the native conformation. The 
peptide searches for N randomly, as if a blind 
golf player would be playing on a totally flat 
golf-course. Figure adapted from [11]. 
 
1.1.2 The classical view of protein folding 
Levinthal’s paradox led to a search for folding pathways. Folding along a predetermined pathway 
is considered the classical view of protein folding. Folding is assumed to start from the denatured 
state (D) and to proceed through a series of well-defined steps to the native state (N). Fig. 1.2 
depicts the folding pathway as a downhill canyon with the denatured state D at its start. The 
canyon may contain valleys and hills representing intermediate and transition states between D 
and N. In molecular terms, the pathway is a well-defined sequence of events such as a series of 
changes in dihedral angles. Most important, the conformational search occurs only along the 
canyon, which limits the search drastically and makes the folding reaction fast.  
 
 
 
 
Figure 1.2. The ‘pathway’ solution to the 
random search problem of Fig. 1.1. The 
denatured state is represented as D and the 
native state as N. Folding of the polypeptide 
chain occurs along a predetermined pathway 
depicted as a canyon in the folding landscape. 
Figure adapted from [11]. 
 
Inherent in the view of a folding pathway is the concept of folding intermediates. It was thought 
that to learn how nature sieves so quickly through the conformational haystack one has to 
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identify intermediate states along the folding pathway. The pioneering papers of 1971 by Ikai and 
Tanford [12] and Tsong, Baldwin and Elson [13] mark the beginning of the search for folding 
intermediates. Major impediments in characterizing folding intermediates are the high 
cooperativity of protein folding and its high speed, which often is in the time range of 
milliseconds. Nevertheless, much effort has been devoted to the characterization of transient 
folding intermediates and a plethora of techniques and experimental designs has been invoked in 
their search. One of the earliest method was kinetic trapping of intermediates during the refolding 
of disulfide bridged proteins, as developed by Wetlaufer [14, 15, 16]. Another early method was 
pulsed chemical labelling introduced by Ghélis [17]. Stopped-flow mixing coupled to circular 
dichroism or fluorescence spectroscopy, and NMR spectroscopy combined with pulsed 
hydrogen-deuterium exchange of transient species provide information at the single amino acid 
residue level [18-20]. Transient folding intermediates can be accumulated by working with 
protein fragments that are unable to complete the folding process. More generally, protein 
engineering can be employed to stabilize intermediates or to probe particular regions of a folding 
protein. Outstanding among the latter methods is the analysis of Φ-values developed by Fersht 
and co-workers [21-23]. 
1.1.3 The new view of protein folding 
While the classical view of protein folding relies on phenomenological models and regards 
folding intermediates in a structural way, the new view emphasizes the ensemble nature of 
protein conformations. Folding is no longer thought to start from the denatured state since D is 
not regarded as a defined starting state like the starting conformation of a small molecule from 
which a chemical reaction initiates. Rather, the denatured state comprises of a very large 
ensemble of states. As a consequence, folding is viewed as a large ensemble of parallel pathways 
involving diffusion-like processes. The folding protein “funnels” to the global minimum state by 
multiple routes in conformational space, which is considered as an energy landscape (Fig. 1.3). 
The Levinthal paradox disappears in the new view of protein folding since the energy landscape 
is not a “flat golf course” but a “downhill slope”.  
An idealized smooth funnel based on an early mean-field lattice model [24] is represented in Fig. 
1.3A. The figure shows how funnels resolve Levinthal’s paradox. An analogy can be drawn 
between the denatured state and an ensemble of skiers distributed at the top of a mountainside 
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(the rim of the funnel). When folding conditions are initiated, each skier glides downhill on his 
own individual trajectory. Skiers reach the global minimum (satisfying Anfinsen’s postulate) by 
many different routes rather than by a single route or folding pathway. Yet they do so in a 
directed and rapid way (easing Levinthal’s concern).  
Fig. 1.3B shows a rough energy landscape with kinetic traps arising from energy barriers; in this 
situation slow and multi-state folding is observed. When local barriers are high, protein 
molecules can be trapped and, depending on the nature of the states, may aggregate. Alternatively, 
some unfolded peptides may fall into a trap (local kinetic minimum) that is not on a pathway 
leading to the native state and an off-pathway intermediate is formed (Fig. 1.4). Peptide B in Fig. 
1.4 can exit the local energy minimum and get back to the folding track. 
In the words of Dobson and Karplus [25] the new view of protein folding “… provides a simple 
way of understanding why the Levinthal paradox is not a real problem”. Indeed, the energy 
landscape and the folding funnel metaphor are a conceptual framework for understanding the 
different scenarios of protein folding as well as misfolding and aggregation. 
 
 
Figure 1.3. Smooth and rough funnels. (A) A smooth funnel represents a two-state folding 
mechanism from any unfolded state (any position on the funnel rim) to the folded state N. There 
is no folding intermediate and folding is very fast. (B) A rugged energy landscape represents 
kinetic traps, energy barriers and some narrow throughway paths. Folding is multi-state and 
proceeds through intermediates. Figure adapted from [11]. 
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Figure 1.4. A folding landscape to illustrate 
off-pathway intermediates. Protein A folds 
by a fast throughway process. Protein B gets 
trapped in a local energy minimum from which 
it may escape to reach the same global energy 
minimum as protein A, yet more slowly. 
Figure adapted from [11]. 
 
1.1.4 Folding models 
Different folding models have attained prominence. They originated from the classical pathway 
view of protein folding. Fig.1.5 shows four long-standing and well-established models. Having 
grown out from theoretical considerations [26-28], molecular simulations [29-32] and 
experimental observations [33-35], the models try to explain the high speed of protein folding. 
Although it is now clear that there is not a single sequential folding route, as is implicit in some 
of these folding models, many features of the models are still valid in the context of the new view 
of protein folding by multiple folding routes in conformational space. 
The nucleation-condensation model – The model of nucleation-propagation, which applies to 
the helix-coil transitions [36, 37], involves a nucleation step followed by rapid propagation to the 
folded state. The nucleation process is considered rate-limiting. The nucleation-condensation 
model proposed by Fersht [38] is a corollary of the older nucleation-propagation model; weak 
local folding nuclei are formed and are stabilized by long range interactions. The nucleation-
condensation model is experimentally well supported for several small proteins including 
chymotrypsin inhibitor II [39, 40] and barstar [41].  
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Figure 1.5. Four prominent folding models. Each model attempts to explain why folding is 
rapid or why Levinthal’s paradox is mistaken. See the text for details. Figure adapted from [42]. 
 
The framework model (diffusion-collision model) – According to this model, local elements of 
secondary structure form first (usually within a few µs) and these then dock to form the native 
tertiary structure of the protein, possibly by a diffusion–collision mechanism. The model 
emphasizes the role of short range interactions in directing  protein folding [43]. A sequential and 
hierarchical model of protein folding has long been generally accepted [33, 44].   
The hydrophobic collapse model (molten globule) – In this model, the protein buries its 
hydrophobic side chains from solvent water early during folding, forming a collapsed 
intermediate also known as a molten globule. The native state develops by a search within the 
conformationally restricted area of the molten globule. This model considers that the first event 
of protein folding consists of a collapse that occurs via long range interactions, before or at the 
same time as the formation of secondary structures [24]. The model was inspired by Kauzmann’s 
hydrophobic effect [6].  
The jigsaw puzzle model – The model was introduced by Harrison and Durbin in 1985 [45]. 
These authors proposed the existence of multiple protein folding pathways, as in the assembly of 
a jigsaw puzzle in which multiple routes exist to reach a unique solution. According to the model, 
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the identification of intermediates attempts a kinetic rather than a structural description, each 
intermediate consisting of heterogeneous species in rapid equilibrium with each other.  
1.2 Protein folding in the cell 
The main rules of protein folding have been deduced from in vitro and in silico studies. Although 
it has been accepted since Anfinsen’s work that in vitro refolding is a valid model to understand 
the folding of a nascent polypeptide chain in vivo, there are important differences between the 
cell and the test tube. The interior of a cell is highly crowded with macromolecules. The total 
protein concentration inside a cell is 200 – 300 mg mL–1, that of RNA is 300 – 400 mg mL–1, and 
polysaccharides also contribute to molecular crowding [46]. Moreover, inside a cell the newly 
synthesized polypeptides enter the cytosol vectorially because the N terminus is synthesized 
before the C terminus. This means the N terminus of a nascent polypeptide is available for 
folding before the rest of the polypeptide, yet folding units or domains cannot occur until the 
chain has reached a certain length [47, 48]. So the question remains: Do the same mechanisms 
account for protein folding in vitro and in vivo?   
1.2.1 The role of molecular chaperones 
Protein folding in the cell is strongly hampered by molecular crowding. As a result, partly folded 
proteins with hydrophobic surface still exposed to the aqueous surrounding may accumulate, 
which may lead to misfolding or aggregation. The efficiency and speed of cellular protein 
synthesis is reduced. Chaperons counteract misfolding and aggregation [49]. These helper 
molecules have been intensively studied and significant progress has been made in the 
understanding of how chaperones assist the folding process [50, 51]. The first molecular 
chaperone identified was nucleoplasmin  involved in mediating the assembly of nucleosomes 
[52]. Over 20 chaperone families have since been identified. Some of the best known are the 
heat-shock proteins Hsp 70 (DnaK in E.coli) and Hsp 40 (DnaJ in E.coli). They show little or no 
specificity for the proteins they assist in folding [53]. They bind transiently to small hydrophobic 
regions of nascent polypeptide chains, preventing aggregation and premature folding. Release of 
the bound protein is often, but not always, regulated in a complex ATP-dependent way. 
The large chaperonins such as the system GroEL-GroES in prokaryotes or the TCP-1 Ring 
Complex (TRiC) in eukaryotes, sequester the unfolded or partially folded polypeptide chain in a 
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central cage. Electron microscopy, high resolution crystallography [54, 55], kinetic studies and 
dynamic fluorescence [56-58] have provided information on the GroEL-GroES machinery. In 
essence, chaperonins smooth the energy landscape for folding by encapsulating the polypeptide 
chain in a folding-friendly environment within the GroEL-GroES macromolecular complex. Such 
behavior has been confirmed in simulations of chaperonin-assisted folding, in accord with 
experimental results [59, 60].  
1.2.2 Misfolding, aggregation and pathological consequences  
Protein aggregation is a widespread phenomenon, often arising from early folding intermediates 
through kinetic competition between proper folding and misfolding. The generally accepted 
hypothesis for protein aggregation is that either in the folding process or as a result of 
fluctuations partially folded intermediates become populated. In the intermediates some 
hydrophobic regions are exposed, thus permitting aggregation. The morphology of aggregates 
can be ordered and leading to amyloid fibrils, or amorphous and resulting in inclusion bodies [61].  
Chaperones alleviate the problem of protein misfolding or aggregation. Still, situations exist 
where chaperones fail, for example under severe stress or when mutant proteins exhibit aberrant 
folding or stability properties. Occasionally, protein misfolding and aggregation can lead to 
diseases, some of them fatal. The formation of amyloid fibrils plays a key role in the origin of 
several pathologies such as spongiform encephalopathies. There are severe neurodegenerative 
diseases associated with an abnormal prion proteins: Kuru, Creutzfeld-Jacob disease (CJD) and 
fatal familial insomnia (FFI) in humans, scrapie in sheep, and bovine spongiform encephalopathy 
(BSE) in cattle. Alzheimer’s disease is also characterized by the presence of amyloid febrile 
deposits in brain tissue. Recent observations have shown that several proteins unrelated to 
amyloid diseases, such as ordinary lysozyme or myoglobin, are able to aggregate in vitro into 
amyloid fibrils that are indistinguishable from those found in pathologic conditions [62-64]. 
Furthermore, species formed early in the aggregation of non-disease associated proteins can be 
cytotoxic [65]. Therefore, the control of misfolding and aggregation is of fundamental 
importance for cell viability.  
In conclusion, it is clear that over the past 25 years our concepts of folding have advanced 
dramatically. As is typical of good research, new insights elicit new questions. Hence, there are 
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plentiful opportunities to dig deeper into the folding problem, both in vitro and in vivo. Advances 
of the future will rely on the synergy between experimental and computational approaches.  
1.3 Repeat proteins 
A large number of protein classes are built on the modularity principle from homologous 
structural blocks [69, 70]. Repeating stretches of similar sequence are found in at least 14% of all 
proteins [69]. The repeats vary from a few amino acids, for example, the polyglutamine tracts of 
the Huntington disease gene product huntingtin, to large repetitions of multiple domains as found 
in the cytoskeletal protein titin. Repeats arise via intragenic duplication and recombination. 
Multiplication of preexisting genetic material enables an organism to expand its repertoire of 
cellular functions, such as protein transport, protein-complex assembly and protein regulation. 
Indeed, the most common function of repeats is to bind other proteins. 
Repeat proteins are found in all phyla but are most common in eukaryotes, particularly in 
metazoans [69]. This may have to do with the increasing complexity of cellular functions of 
higher organisms. One attractive hypothesis is that repeat proteins evolve more quickly than non-
repeat proteins. Eukaryotes possess a sophisticated protein synthesis machinery to handle the 
multi-domain, non-globular folds of repeat-rich proteins. Eukaryotes may use this as an 
advantage over prokaryotes to gain from the benefits offered by repeats: modular construction of 
new proteins and introduction of rapidly evolving protein sequences that allow faster adaptation 
to new environments [69].  
1.3.1 Structural organization of repeat proteins 
Repeat proteins consist of a number of structurally identical motifs usually arranged in tandem 
and stacked together to form elongated or supercoiled shapes [71]. Repeating modules are 
typically 20-40 residues long and contain secondary structure elements that fold in a variety of 
topologies [72]. The linear assemblage of complementary repeats results in a relatively simple 
and robust scaffold, which is maintained by the regular repetition of hydrophobic contacts and 
hydrogen bonds. The architecture of stacked elements implies that stabilizing contacts are either 
within one repeat or between adjacent repeats. There are hardly any contacts between residues of 
non-adjacent repeats. 
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1.3.2 Major classification of repeat proteins 
Repeat proteins have been classified into six families according to secondary and tertiary 
structure elements [73].  
secondary structure repeat families 
all α structure armadillo/HEAT 
tetratricopeptide repeats 
all β structure β-propellers 
β-trefoils 
mixed α/β structure leucine-rich repeats 
ankyrin repeats 
 
Repeats containing only α-structures – The 42 amino acid armadillo repeat (arm motif) [74] was 
identified in the product of the Drosophila melanogaster segment polarity gene [75]. It has since 
been found in several eukaryotic proteins including β-catenin, importin α, the tumour suppressor 
adenomatous polyposis coli (APC), etc. The arm motif consists of three α-helices associated to a 
superhelical structure. The first helix is short (about 8 residues) and lies perpendicular to the 
other two longer α-helices that pack against one another. The function of tandem arm repeats is 
to bind proteins, which is achieved by a long groove extending along the superhelix axis created 
by the repetitive arm motifs. Fig. 1.6 shows the nuclear import receptor importin α containing 10 
arm repeats [76].  
The HEAT motif (Fig. 1.7) is a repetitive sequence that was first observed to be common to the 
Huntingtin protein, elongation factor 3, PR65/A subunit of protein phosphatase A, and the target 
of rapamycine (TOR) [77]. HEAT motifs vary in length between 37 and 43 residues and occur in 
tandem arrays of between 3 and 22 motifs. Occasionally blocks of tandem repeats are dispersed 
throughout the sequence. HEAT motifs are also present in importins β1 and β2, in proteins 
related to the clathrin-associated adaptor complex and in many other proteins related to 
chromosome dynamics [78]. HEAT motifs are involved in protein-protein interactions. HEAT 
repeats have two anti-parallel α-helices. The first HEAT helix has a kink (of variable extent) that 
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makes it equivalent to both the first and second helices of armadillo repeats. The parallel stacking 
of repeat units produces a solenoid.  
 
Figure 1.6. Armadillo repeats of importin alpha (PDB code: 1IAL). Different arm repeats are 
colored differently;  the N-terminal auto inhibitory segment is in magenta [76]. 
 
 
Figure 1.7. Ribbon diagram of the transport factor karyopherin-β2 with 18 HEAT repeats 
(PDB code: 1QBK) [79]. Repeats are differently coloured and labelled HR1–HR18. The N-
terminal capping helices NαA and NαB) are red and the C-terminal capping helices CαA and 
CαB are pink. Loop L7 is dark green; it connects the helices of HR7 with the short α-helical 
regions α1, α2 and α3. 
 
The tetratricopeptide repeat (TPR) was identified in 1990, the name denoting the 34 amino 
acids of the basic repeat [80, 81]. The 34 amino acids are arranged in two α-helices packed 
together in a knobs-in-holes manner. The TPR is likely to be an ancient repeat since it is found in 
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eukarya, bacteria, and archaea [82]. Multiple TPRs form a right-handed super helix and show 
multiple modes of ligand binding in a large groove [83]. Fig. 1.8 shows the crystal structure of a 
designed TPR motif [84]. TPRs come in many different flavours that form distinct sequence 
subfamilies. They are present in kinesin light chains, SNAP secretory proteins, clathrin heavy 
chains and bacterial aspartylphosphate phosphatases. Malfunctioning of a TPR-protein is linked 
to human diseases [85, 86]. 
 
 
 
 
 
 
 
Figure 1.8. Crystal structure of designed TPR 
repeat protein CTPR3 consisting of three repeats 
(PDB entry: 1NA0). Repeat 1 is yellow, repeat 2 is 
red, repeat 3 is blue, and the capping helix is green 
[84].  
 
Repeats containing only β-structures – The WD40 repeat, also known as a β-propeller, is the 
most common repeat among the known human proteins [87]. The motif contains approximately 
40 residues and includes well-conserved tryptophan and aspartic acid residues. The crystal 
structure of an assembly of seven WD40 repeats (Fig. 1.9) reveals that each repeat represents a 
four-stranded antiparallel β-sheet (a “blade”) arranged radially in a “propeller” arrangement 
about a central axis. Seven-blade β-propellers are found in methylamine dehydrogenase (PQQ 
repeats), regulator of chromosome condensation 1 (RCC1 repeats) and galactose oxidase (Kelch 
repeats). Neuraminidase features a six–blade propeller. The propeller structure is closed through 
interactions between the N- and C-terminal repeats. Again, a common function of β-propellers is 
to bind ligands and other proteins  through a ligand binding “supersite” formed by the N-termini 
of interior β-strands [88].  
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Figure 1.9. Structure of Ski8p, a protein 
regulating mRNA degradation with a 
seven-blade β-propeller [89]. Each 
propeller consists of four anti-parallel β-
strands. 
 
β-trefoils are another type of all β-sheet “closed” structures. The β-trefoil has six two-stranded β-
hairpins, three of which form a barrel structure while the remaining three form a triangular cap on 
the barrel [90]. The fold occurs in fibroblast growth factor (FGF), interleukin-1, Kunitz soybean 
trypsin inhibitor and ricin-like toxin. Four β-trefoils are found in actin-binding fascin. By contrast 
to the β-propellers, the β-trefoils do not appear to possess a “supersite” for ligand binding since 
they bind the ligands in different locations [88].  
Repeats containing α/β structures – Leucine-rich repeats (LLRs) were first identified in the 
leucine-rich α2-glycoprotein [91]. LRRs are 20–29 residues long and contain a conserved 11-
residue segment and consist of a β strand and an α helix connected by loops [92]. The repeats are 
arranged so that all the strands and helices are parallel to a common axis, resulting in a 
nonglobular, horseshoe-shaped molecule with a curved parallel β sheet lining the inner 
circumference of the horseshoe and the helices flanking the outer circumference, as shown in Fig. 
1.10.  
LRR proteins participate in hormone–receptor interactions, enzyme inhibition, cell adhesion, 
cellular trafficking, etc. They are involved in early mammalian development [93], neural 
development [94], cell polarization [95], regulation of gene expression [96] and apoptosis 
signaling [97].  
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Figure 1.10. Crystal structure of ribonuclease 
inhibitor RI (PDB code 2BNH). LRRs are shown in 
blue and an additional subunit is in red. 
 
Ankyrin repeats (AR) take their name from the human erythrocyte protein ankyrin where they 
were detected first [98]. AR proteins occur in virtually all species, but the majority is found in 
eukaryotes where they are involved in a wide range of cellular tasks ranging from transcriptional 
regulation to cytoskeleton organization [99]. The AR is a 33 residues L-shaped motif of two anti-
parallel α-helices connected by a short loop [100]. The consecutive repeats stack in parallel and 
are joined by β-hairpins forming the base of the L. The crystal structure of the ankyrin domain of 
Bcl-3, a unique member of the IκB protein family [101], is shown in Fig. 1.11. AR proteins bind 
various other proteins that are not restricted to a single class. There is good evidence for complex 
formation with p53 (a nuclear tumor suppressor), CDK6 (a cell division kinase) and p65 (a 
transcriptional regulator). Another interaction is between the developmental AR protein Notch 
and deltex, a cytoplasmic protein [102]. Some mutations of AR proteins are linked to human 
diseases [103, 104]. 
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Figure 1.11. Crystal structure of the ankyrin domain of Bcl-3, a member of the IκB family (PDB 
code: 1K1A). Helices colored red and yellow, β-sheets colored blue.  
 
 
1.4 Goals of this thesis 
Unlike globular proteins, the structure of repeat proteins is dominated by local, short-range 
interactions. Hence, the folding and stability of repeat proteins may differ from that of similarly 
sized globular proteins. The goal of this thesis was to look into such potential differences. When I 
had started this work three years ago, there was very few information available on the kinetics of 
folding of repeat proteins.  
I have chosen two repeat proteins as representative examples for my studies: a small ankyrin with 
an α/β structure and a small tetratricopeptide-like all-α protein from Helicobacter pylori featuring 
one disulfide bond per repeating motif.   
Work on the ankyrin repeat is described in Chapter 2. The protein was randomly selected from a 
designed consensus library constructed by Binz et al. [107]. It is one of the shortest possible 
ankyrins composed of only a single repeat flanked by N- and C-terminal capping repeats. This 
simple structure was a good starting point for my investigations. Indeed, under some benign 
conditions folding can be described as a single-step U →N reaction, much like the folding of a 
small globular protein. Under other conditions, however, there is evidence for multi-step folding.  
Work on the H. pylori cysteine-rich repeat protein is described in Chapter 3. The protein 
consists of 4 repeating units and was chosen because of its unique disulfide pattern. Since the 
disulfide bonds are consecutive, one per repeating unit, we asked if disulfide formation also 
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proceeds consecutively, or if non-native disulfides appear as transient intermediates to be later 
reshuffled to the native consecutive order. The answer is unequivocal: Oxidative formation of the 
disulfide bonds is consecutive both in vitro and in vivo.  
In the final Chapter 4, I present my preliminary work on the kinetics of folding of the disulfide-
linked heterodimeric leucine zipper ABSS designed in our laboratory to understand the effect of 
salt bridges on protein stability [109]. It had been shown that leucine zipper ABSS is more stable 
at acidic pH and that the stability difference between acidic and neutral pH was larger when 
deduced from GdmCl unfolding than from urea unfolding. Hence, here was a system to look into 
the longstanding problem of different effects of GdmCl and urea on protein unfolding. The aim 
was to demonstrate a charge-screening effect of GdmCl as a cause for the different behavior of 
the two denaturants.  
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2 Folding of an Ankyrin Repeat Protein 
2.1 Introduction 
Proteins are often classified on the basis of the conserved sequence motifs that they contain, 
although the function and structure of the motif might be uncertain. In 1987, Breeden and 
Nasmyth reported a ∼33 residue repeating motif in the sequence of two yeast cell-cycle regulators, 
Swi6p and Cdc10p, and in the Notch (Drosophila melanogaster) and LIN-12 (Caenorhabditis 
elegans) developmental regulators [1]. The discovery of 24 copies of this sequence in the 
cytoskeletal protein ankyrin led to the naming of this motif as the ankyrin repeat [2]. Ankyrin 
repeat (AR) proteins carry a wide variety of biological activities and are present in all three super 
kingdoms including bacteria, archaea, and eukarya, as well as in a number of viral genomes. AR 
proteins are localized in the nucleus (e.g., IκBα), cytoplasm (e.g., ankyrin), anchored to the 
membrane (e.g., notch), and secreted into the extracellular space (e.g., black widow spider toxin), 
which indicates that these proteins can adapt to many different environments. Their biological 
importance is highlighted by the fact that there are more than 2000 known AR proteins with over 
14,000 repeats [3]. Some AR proteins consist solely of ankyrin repeats; others are multi-domain 
molecules, in which ARs are combined with unrelated structural modules. So far the main known 
function of AR proteins is to mediate protein-protein interactions. The corresponding complexes 
are essential for many cellular processes such as cell differentiation, endocytosis, transcription 
regulation, and cell cycle control.  
A number of ankyrin repeat proteins have been linked to human diseases. For example, the 
mammalian cell cycle inhibitor p16 is encoded by the INK4a gene, which is a frequent site of 
mutations that are strongly associated with cancer [4]. A mutation in the ankyrin repeats of 
human Notch3 is associated with a hereditary adult-onset condition causing stroke and dementia 
[5].  
2.1.1 Structural organization of ankyrin repeats (AR) 
Almost ten years after the discovery of the AR motif, the first three-dimensional structure of an 
ankyrin repeat molecule, 53BP2 bound to the p53 cell-cycle tumour suppressor was determined 
[6]. This and subsequent structures have shown that AR proteins are composed of stacked ARs, 
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consisting typically of 33 amino acid residues, each forming two antiparallel helices with a β-
hairpin/loop region projecting outward from the helices at a 90° angle. Because the set of helices 
that face away from the β-hairpin/loop region are slightly longer, the stacked repeats form a 
concave L-shaped structure (Fig. 2.1). The inter-repeat interface consists of hydrophobic 
interactions stabilizing the interface between the helices of consecutive repeats in addition to a 
hydrogen bonding network connecting the β-hairpin/loop region. Usually, four to six repeats 
assemble into domains [7], but the crystal structure of ankyrin R consisting of 12 ARs in a single 
domain [8] and the presence of 29 consecutive repeats in a single protein [9] indicate that there is 
virtually no limit to the number of repeats that can fold in one AR domain.   
 
Figure 2.1 The structure of the ankyrin domain of the hepatocellular carcinoma-associated 
protein gankyrin (PDB code: 1UOH). The ribbon representation shows five internal ankyrin 
repeats along with flanking N- (blue) and C-termini (red) repeats and antiparallel β-hairpins [10]. 
 
To date, the structures of 13 naturally occurring and three designed ankyrin repeat proteins have 
been solved. These structures closely resemble one another despite their different cellular 
functions, supporting the role of the ankyrin repeat as a versatile scaffold for protein–protein 
interactions. Indeed, it appears that the ankyrin repeat motif is defined by its fold rather than by 
its function, since no specific sequence or structure motif that is universally recognized by AR 
has been identified so far.  
Consensus design of ankyrin repeats (AR) – The stacked L-shaped structure of ankyrin repeats 
has evolved as a scaffold for various protein-protein interactions. The motif may serve as a 
template or building block for protein engineering and design studies. Due to the large number of 
currently available sequences, it is an especially attractive model for consensus-based protein 
design.  
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Recent efforts at designing ankyrin repeat proteins using sequence-based strategies have been 
successful [11, 12]. Mosavi et al. performed statistical analyses on ∼4400 ankyrin repeat 
sequences deposited in the PFAM database to create a consensus sequence, or idealized ankyrin 
repeat [11]. Their analyses consisted of classifying the conservation-level of each position based 
on the amino acid occurrence at that position, the amino acid distribution over the entire sequence, 
and the secondary structure elements corresponding to each position. The ensuing sequence was 
used to construct proteins consisting of one, two, three, or four identical repeats (Fig. 2.2).   
 
Figure 2.2 The structure of a consensus designed ankyrin repeat protein containing four 
identical sequence repeats by Mosavi et al. [11]. Individual repeats are colored differently 
from N- to C-terminus (PDB code: 1N0R).  
 
Binz et al. used a different strategy. To create a consensus ankyrin sequence, they started with the 
statistical analysis of 229 repeats from the SMART database and included information from 10 
existing high-resolution structures of ankyrin repeat proteins [12]. They designed a consensus AR 
consisting of fixed framework residues and randomized interacting residues. N- and C- terminal 
“capping” repeats derived from the structure of GABP-β were incorporated into the design. The 
role of the capping repeats is to shield the hydrophobic core of the first and last internal AR from 
the solvent. To form a potential interaction surface, positions 2, 3, 5, 13, 14, and 33 (numbering 
for first repeat) in the shorter helix and β-hairpin region were randomized to contain any amino 
acid except glycine, proline, or cysteine. Varying numbers of internal repeats were inserted 
between the N- and C-terminal caps. As a result, designed AR protein libraries of distinct repeat 
numbers were obtained. The nomenclature is N2C, N3C, N4C, etc., where N and C denote the 
caps and digits denote the number of consensus repeats. The X-ray crystal structure of the N3C 
library member E3_5 (a five-repeat library member) is shown in Fig. 2.3. The structure is well-
packed adopting a regular ankyrin repeat fold [13]. Using this consensus design, Binz et al. have 
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generated combinatorial libraries of AR proteins of varying repeat numbers with diversified 
binding surfaces. Successful selection of library members that bind with high affinity to 
Escherichia coli maltose binding protein (MBP) and to two eukaryotic mitogen-activated protein 
kinases (MAPKs) was achieved recently [14]. 
 
 
Figure 2.3 Crystal structure of E3_5 (PDB entry: 1MJ0), a designed ankyrin repeat protein 
consisting of five repeats (N3C). Residues represented as red sticks are randomized positions 
that build a large potential interaction surface. The N and C-terminal capping repeats are in green 
and the internal repeat modules are in blue [13].  
 
2.1.2 Folding studies of natural ankyrin repeats 
Until recently folding studies have focused mainly on globular proteins. Ankyrin repeats 
represent a class of proteins with an elongated structure and little or no long-range contacts. From 
a folding perspective, the modular nature of ankyrin repeat domains presents a number of 
interesting questions. Unlike the packing of globular protein domains, the linear packing of the 
repeat modules in AR proteins implies that local, regularly repeating packing interactions are 
very important and may dominate the thermodynamic stability and the folding mechanism. One 
is tempted to assume that AR proteins fold in a modular, multistate reaction controlled by short-
range interactions. Interestingly, however, folding studies on a number of naturally occurring 
ankyrin repeat proteins show that the ankyrin repeat domain follows an apparent two-state folding 
pathway. The ankyrin domain of Drosophila Notch (a signaling protein with 7 AR)  and two 
variants with one or two C-terminal repeats deleted fold in a two-state manner [15]. The ankyrin 
domain of Notch has an unfolding free energy of ∆GH2O = 8.03 kcal mole–1. The human AR 
proteins p16 (four AR) and p19 (five AR), both members of the INK4 tumor suppressor family, 
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show three refolding phases at low urea concentrations and one unfolding phase [16, 17]. Some 
truncation studies of AR proteins suggest that four to six repeats are necessary to form a stably 
folded structure, and that a single repeat is not capable of folding [18]. On the other hand, 
truncation studies of the AR protein p16 demonstrate that the C-terminal two repeats form an 
autonomously folded unit and suggest that two repeats are the minimum folding unit of the 
ankyrin repeat [19].   
2.1.3 Stability of designed ankyrin repeats   
Thermal melting and equilibrium unfolding studies have been performed on randomly selected 
members of the designed ankyrin consensus library by Binz et al. [12, 13]. All the selected 
proteins had well-folded structures and were stable. Equilibrium unfolding studies with GdmCl 
of designed four, five and six AR proteins showed cooperative and reversible unfolding with 
∆GH2O between 9.5 and 21 kcal mol-1. When compared to naturally occurring AR proteins, the 
thermodynamic stability of the designed repeat proteins is quite high. Thermal melting midpoint 
temperatures (Tm) are in the range of 66 °C to 85 °C depending on the number of repeats [12]; 
naturally occurring AR proteins have Tm of 50 °C or less [15, 20]. Obviously the designed AR 
proteins are tightly folded and very stable.  
To further characterize the behavior of the “idealized” consensus AR used in the library of Binz 
et al., we have investigated the stability and folding of one randomly chosen member of the N1C 
library consisting of a single consensus AR flanked by terminal capping repeats.   
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2.3 Folding of a designed simple ankyrin repeat protein 
 
V. Sathya Devi, H. Kaspar Binz, Michael T. Stumpp, Andreas Plückthun, Hans Rudolf Bosshard 
and Ilian Jelesarov 
 
Protein Science 13, 2864-2870 (2004) 
 
Folding of an Ankyrin Repeat Protein CHAPTER 2 
 
38 
Folding of an Ankyrin Repeat Protein CHAPTER 2 
 
39 
Folding of an Ankyrin Repeat Protein CHAPTER 2 
 
40 
Folding of an Ankyrin Repeat Protein CHAPTER 2 
 
41 
Folding of an Ankyrin Repeat Protein CHAPTER 2 
 
42 
Folding of an Ankyrin Repeat Protein CHAPTER 2 
 
43 
Folding of an Ankyrin Repeat Protein CHAPTER 2 
 
44 
 
 
 
 
Disulfide Bond Formation in a Repeat Protein CHAPTER 3 
 
45 
3 Formation of Disulfide Bonds in a Cysteine-rich Repeat Protein  
In this Chapter I first review the newly detected family of cysteine-rich repeat proteins from 
Helicobacter pylori (section 3.2) followed by a general discussion on how to study disulfide bond 
formation in proteins (sections 3.3 and 3.4). Section 3.5 is a submitted manuscript describing my 
work on the oxidative refolding of the cysteine-rich repeat protein HcpB from H. pylori. 
Additional experiments on the stability and folding of HcpB are presented in section 3.6.  
3.1  Helicobacter pylori 
Helicobacter pylori (Fig. 3.1) is a micro-aerophilic, spiral shaped, gram negative bacterium 
discovered in 1983 by Warren and Marshall [1]. It lives in the stomach and duodenum and has a 
unique way of adapting to the harsh environment of the stomach. It settles in the gastric mucosa 
of primates and is a major risk factor for several gastric diseases such as chronic active gastritis, 
gastric adenocarcinoma and MALT lymphoma [2-6].  
 
 
Figure 3.1. Computer-designed image of 
H. pylori. The gram negative bacterium has 
a curved shape and flagella that enable it to 
propel itself into the mucus lining of the 
stomach. The image was taken from 
http://www.faseb.org/opa/pylori/pylori.html.   
 
Strain-specific genetic diversity has been proposed to be involved in the organism's ability to 
cause different diseases and to participate in lifelong chronic infection. Because of its importance 
as a human pathogen, the genomes of the two strains 26695 and J99 have been completely 
sequenced and may provide information for drug discovery and vaccine development [7, 8]. The 
genomes’ open reading frames (ORFs) were grouped into 95 families. For approximately two-
thirds of all ORFs, a function was assigned by sequence comparison. A group of seven ORFs that 
are unique to H. pylori has been identified. This group is called family 12 [7] and no clear 
function can yet be assigned to it. The sequences, which are annotated as "hypothetical proteins," 
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may become a rich source of information if their structures and biological functions can be 
investigated.  
3.2 Cysteine-rich repeat proteins from Helicobacter pylori  
Sequence analysis revealed that members of family 12 possess a modular architecture of α/α-
units and are rich in cysteine residues. The gene products of family 12 are designated as 
Helicobacter cysteine-rich proteins (Hcps). Hcps, which are unique to the Helicobacter and 
Campylobacter genera, have a mass between 15 and 40 kDa and show a conserved pattern of 
cysteine pairs. Two cysteine residues are separated by 7 amino acids, and there are 36 amino 
acids between adjacent cysteine pairs. The Hcp proteins HcpA, HcpB, HcpC and HcpE consist of, 
respectively, six, four, seven, and nine repeats of a common α/α-motif. Sequence conservation 
among Hcp proteins varies between 22 and 66% sequence identity.  
Hcp proteins belong to the large group of SEL1-like tetratricopeptide repeat (TPR) proteins [9]. 
They seem to be involved in the Th1 cell-dependent inflammatory response exerted by H. pylori 
infection [10]. Some Hcp proteins, such as HcpA, HcpB and HcpD, bind and hydrolyse penicillin 
derivatives [11-13]. Whether these in vitro activities indicate an implication of Hcp proteins in 
cell-wall biosynthesis remains elusive.  
3.2.1 Structures of HcpB and HcpC 
The crystal structures of HcpB and HcpC (Fig. 3.2) have been solved [12, 14]. The structure of 
H. pylori cysteine-rich protein B (HcpB) consists of four α/α-motifs that are cross-linked by 
disulfide bridges [12]. Four disulfide bridges are observed between cysteine pairs Cys-22/Cys-30, 
Cys-52/Cys-60, Cys-88/Cys-96, and Cys-124/Cys-132. The disulfide bridges subdivide the 
structure into four pairs of α-helices named A and B. The helices have variable length. The two 
cysteines forming a disulfide bridge between helices A and B are located at the C-terminus of 
helix A and close to the N-terminus of helix B. The four α-helix pairs of HcpB have very similar 
conformations and the sequence identity for the pairwise alignment is 33 to 58%. Although the 
overall sequence composition of the first repeat is similar to that of the other repeats, the structure 
of the first repeat is quite different. This is due to a different loop connecting helices A and B of 
the first repeat.  
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Figure 3.2.  Panel A. Crystal structure of HcpB (PDB code: 1KLX). Disulfide bridges are 
highlighted as light green balls and the four repeats consisting of two helices each are differently 
coloured differently [12]. Panel B. Crystal structure of HcpC (PDB entry: 1OUV). The N-terminal 
capping helix (green), helix A (pink) and helix B (blue) of each repeat are shown. The disulfide 
bridges are indicated as light green balls between the helices of each repeat [14]. 
 
The crystal structure of HcpC (Fig. 3.2) shows that it consists of 15 antiparallel α-helices and is 
subdivided into seven repeats, each 36 residues long [14]. HcpB and HcpC share 46% sequence 
identity. HcpC has an N-terminal capping repeat to shield the first repeat from solvent and to 
stabilizes the elongated hydrophobic core. Similar N-terminal capping helices are predicted for 
all Hcp family members, except for HcpB, and are found frequently in solenoid proteins [15, 16]. 
In HcpB, the first repeat seems to act as a capping repeat.  
The presence of disulfide bridges is a unique feature of Hcp proteins. Disulfide bonds have been 
reported only in one structurally unrelated anti-freeze repeat protein. Apart from anti-freeze 
repeat proteins, Hcps are the only repeat proteins that possess disulfide bridges.  
3.2.2 Comparison of HcpB with tetratricopeptide repeats (TPR) 
The modular architecture of Hcps shows that they belong to the large group of SEL1-like 
tetratricopeptide repeat (TPR) proteins. Data base searches revealed that the structure of HcpB is 
most similar to the TPR domain of human phosphatase 5 [17]. The isolated PP5 TPR repeats (Fig. 
3.3) superimpose well onto the HcpB structure. The TPR and Hcp repeats consist of 34 and 
Disulfide Bond Formation in a Repeat Protein CHAPTER 3 
 
48 
36 amino acids, respectively. In HcpB the inter- and intra-repeat helix packing angles differ 
substantially from each other (14° and 42°, respectively), in contrast to the uniform packing angle 
of ~24° found in TPR proteins.  
 
 
 
 
 
Figure 3.3. Crystal structure of 
tetratricopeptide repeats of human protein 
phosphatase 5 (PDB code: 1A17). The three 
repeats (TPR1, TPR2 and TPR3) and an 
extended C-terminal α-helix are shown [17]. 
The three repeats superimpose well with the 
repeats of HcpB. 
 
3.3 Studying disulfide bond formation in vitro 
Identifying intermediates and transition states on the way from the unfolded to the folded protein 
is a main goal of protein folding studies. For proteins containing disulfide bridges, the 
identification and characterization of disulfide-containing intermediates is relatively easy [18]. 
This is because the formation or reduction of a disulfide bond is a localized, two-state, 
structurally well-defined reaction and disulfide species are stable, covalent intermediates that can 
be isolated [19]. The rates of disulfide-bond formation and reduction can be varied without 
significantly altering other interactions, e.g., by changing the concentrations of the redox agents 
or by changing the pH. Capturing and analysing disulfide intermediates provides clues about the 
folding pathways of the proteins. Using disulfide bond formation to study protein folding 
necessitates that the folded protein conformation requires at least one disulfide for stability. In the 
absence of denaturant and under conditions leading to folding, the reduced protein should be at 
least partly unfolded [20, 21].  
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3.3.1 The chemistry of disulfide bond formation 
Disulfide bond formation is based on thiol/disulfide exchange according to [22]: 
R1S– + R2SSR3 → R2S– + R1SSR3 
The thiolate anion R1S– of the reducing agent displaces one sulfur of the disulfide bond R2SSR3 
of the protein. Disulfide bonds are formed and reduced by two such thiol/disulfide exchange 
reactions with a redox agent, the first of which involves the formation of a mixed disulfide bond 
between the protein and the redox reagent. Thiol/disulfide exchange reactions can also occur 
intramolecularly; for example, a protein thiolate group may attack a disulfide bond of the same 
protein, leading to disulfide reshuffling. Redox agents like reduced and oxidized cyclic 
dithiothreitol (DTTred ⇄ DTTox) and oxidized and reduced linear glutathione (GSSG ⇄ 2 GSH) 
can be used. Disulfide bond reactions are sensitive to the concentration of the redox agents, pH of 
the solvent, pKa values of the thiol groups and accessibility of the disulfides of the protein. Since 
thiol/disulfide exchange requires the thiolate anion, acidification quenches disulfide bond 
formation, disulfide reduction and thiol/disulfide exchange [23].   
3.3.2 Trapping and identification of disulfide intermediates 
Chemical trapping – Traditionally, folding intermediates have been trapped by the addition of 
iodoacetate, a reagent that alkylates free thiols to prevent oxidation or thiol/disulfide exchange. 
Rearrangement of intermediates during trapping with iodoacetate has been observed for BPTI [23] 
and ribonuclease A [24]. Rearrangement occurs because thiol/disulfide exchange proceeds on the 
same time scale as alkylation by iodoacetate. This is a severe problem if steric hindrance retards 
the rate of thiol alkylation of an intermediate [25]. Although a large excess of iodoacetate can be 
applied to minimize the side reaction, modification of other functional groups by the high 
concentration of iodoacetate may cause other problems [26].  
Rothwarf and Scheraga used 2-aminoethyl methanethiosulfonate (AEMTS) as a trapping agent 
for trapping the disulfide intermediates of bovine ribonuclease A. AEMTS reacts specifically 
with thiol groups and much more quickly than iodoacetate, preventing thiol/disulfide exchange 
[24]. Selective labeling of cysteines has also been achieved with colored and fluorescent reagents 
[23, 29].  To identify trapped cysteine-containing intermediates, the protein is digested by 
Disulfide Bond Formation in a Repeat Protein CHAPTER 3 
 
50 
suitable proteases, peptides are separated and analyzed by mass measurements. By such peptide 
mapping one can identify the fragments that contain oxidized disulfide bridges or reduced and 
modified cysteines. 
Acid quenching – Acid quenching is an alternative technique for providing ‘snapshots’ of the 
refolding of cystinyl proteins. Because the thiolate anion is the reactive species in thiol/disulfide 
exchange, it is possible to rapidly quench the folding process by lowering the pH. Acid-quenched 
intermediates can be separated by reversed-phase high-performance liquid chromatography 
(HPLC) at acidic pH without significant reshuffling of the trapped species. Acid quenching is 
reversible. Therefore, an acid-quenched intermediate can be purified at low pH and allowed to 
reshuffle again at slightly alkaline pH [23, 27]. However, intermediates trapped by acid must be 
chemically modified to determine the disulfide bond structure.    
Acid quenching and chemical trapping by cyanylation – A new method has been developed 
by Watson and co-workers to assign disulfide bond pairings by partial reduction, cyanylation, 
cleavage and mass mapping [28]. The modifying reagent is 1-cyano-4-dimethylamino-pyridinium 
tetrafluoroborate (CDAP). It specifically cyanylates free cysteines at acidic pH, a clear advantage 
over other chemical trapping reagents that usually work only at neutral to alkaline pH (Scheme 
3.1). The cyanylation reaction is carried out at pH 3 to minimize disulfide exchange. Cyanylation 
is quantitative and specific for free sulhydryl groups. The side chains of Met, Ser, Thr, acidic and 
basic amino acids are not modified by CDAP. We have used acid quenching with cyanylation to 
trap free cysteines of HcpB during the oxidative refolding (section 3.5) and the reductive 
unfolding reaction (section 3.6.1). 
 
 
 
 
 
 
 
Scheme 3.1. Cyanylation reaction of CDAP. 
CDAP cyanylates sulfhydryl groups at acidic pH 
[28].  
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3.4 Studying disulfide bond formation in vivo 
In the cell, disulfide bond formation is a catalysed process [30]. In E. coli, disulfide bonds are 
introduced in the periplasm by the Dsb proteins ("Dsb" stands for disulfide bond formation). The 
oxidation of cysteine pairs of substrate proteins is achieved by the highly oxidizing DsbA/DsbB 
catalytic system (Fig. 3.4). The oxidizing power utilized by DsbA is delivered by DsbB, which 
obtains the “oxidative power” from a membrane-embedded electron transport system utilizing 
molecular oxygen as the terminal oxidant [31].  
The DsbC/DsbD system has the ability to reduce disulfide pairs, which are then again re-oxidized 
by the DsbA/DsbB system (Fig. 3.5). In this way, non-native, i.e., wrongly formed disulfide 
bridges can be re-opened and the native disulfide pattern is found by “trial and error”. The 
DsbC/DsbD system is sustained by a constant supply of reducing power from the cytoplasmic 
thioredoxin system, which utilizes NADPH as the ultimate electron source [31] 
 
Figure 3.4. DsbA/DsbB system to oxidize cysteines in the periplasm of E.coli. DsbA interacts 
with a folding protein containing reduced cysteines, oxidizing them to form disulfide bonds. 
DsbA is re-oxidized by the inner membrane protein DsbB. Under aerobic conditions, DsbB is re-
oxidized by ubiquinone, which passes the electrons to cytochrome oxidase and finally to 
molecular oxygen. Under anaerobic conditions, DsbB is re-oxidized by menaquinone, which 
passes the electrons to some anaerobic electron acceptor. Figure taken from [31].  
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Figure 3.5. DsbD/DsbC system to reduce disulfide bonds in the periplasm of E.coli. DsbC 
reduces disulfide bonds, allowing these to rearrange to their native pairings. DsbC is reduced by 
DsbD. DsbD is reduced by cytoplasmic thioredoxin, which is reduced by NADPH. Figure taken 
from [31].  
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Helicobacter pylori cysteine rich proteins (Hcps) are disulfide-containing repeat 
proteins. The repeating unit is a 36-residue helix-loop-helix motif with a disulfide bridge 
between the helices. We use HcpB containing four repeats arrayed in tandem as a model to 
study the formation of disulfide bonds in a repeat protein. In vivo oxidative refolding was 
conducted in the periplasm of Escherichia coli. Disulfide bonds appear consecutively in the 
direction of export into the periplasm and there is no evidence of rearrangement of non-
native disulfide bonds. This follows from the observation that folding needs only DsbA and 
DsbB, the catalysts of disulfide bond formation, but not DsbC and DsbD, the catalysts for 
rearranging non-native disulfide bonds. In vitro, the oxidative refolding in the presence of 
glutathione redox buffer also proceeds without the apparent formation of incorrect 
disulfide bonds. Three intermediates were observed: HcpB1SS, HcpB2SS and HcpB3SS with 
one, two and three disulfide bonds, respectively. Intermediates HcpB1SS and HcpB2SS are 
molecular mixtures with correct disulfide bonds in any one of the four repeats. HcpB3SS is 
the major folding intermediate with disulfides in repeats 2, 3 and 4 and reduced cysteines in 
repeat 1. Rate-limiting formation of the last disulfide bond is strongly coupled to the folding 
of the N-terminal repeat 1 and contributes about half of the thermodynamic stability of 
HcpB, which is 27 kJ mol–1 at 25 °C and pH 7. This may be explained by the N-terminal 
repeat acting as a cap to stabilize the folded molecule.  
 
Repeat proteins are built of structurally identical motifs arranged in tandem to form 
elongated shapes as found, for example, in ankyrin, tetratricopeptide or leucine rich repeat 
proteins. Such proteins are involved in signaling and regulatory pathways and function as 
versatile scaffolds for protein-protein interactions (1). Designed repeat proteins have great 
potential as binding partners (2,3). The repeating motifs typically have 20–40 residues forming 
secondary structures that coalesce in various topologies (4). The linear stacking of repeat 
modules produces local, short-range packing interactions at the inter-repeat interface.  
A family of cysteine containing repeat proteins has been detected as open reading frames 
in the genome of Helicobacter pylori (5,6). Gram negative H. pylori has been made responsible 
for several gastric and duodenal diseases (7,8). The precise biological function of Hcps 1 is not 
known, but it was found that some Hcps bind β-lactam compounds (6,9) and seem to be involved 
in the innate immune response (10). The proteins are built of several consecutive, 36-residue long 
α/α motifs, the anti-parallel α-helices of the motif being connected by a short loop. The structure 
belongs to the Sel1-like protein family, a subfamily of the tetratricopeptide repeat proteins (1). 
The α-helices of the Hcp motif are bridged by a disulfide bond, a unique feature not found in 
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other repeat proteins. The shortest Hcp family member is the 16 kDa protein HcpB with four 
repeat units and four disulfides bridges (Fig. 1) (11).  
The formation of an array of motifs of a repeat protein may differ from the folding of a 
similarly sized globular protein because molecular packing in a repeat protein occurs mainly by 
consecutive short-range interactions. Intra-repeat and inter-repeat interactions affect the folding 
mechanism and the overall stability increases with the number of repeats (12,13). There are few 
detailed studies on the stability and folding kinetics of repeat proteins. Even in the simple case of 
an ankyrin with only three repeats, rapid folding seems to proceed through intermediates (14). 
The folding of designed tetratricopeptide repeat proteins was shown to be governed by 
interactions within and between the repeating motifs and is very rapid (13).  
Protein disulfide formation in vivo has been well characterized (short reviews in (15,16)). 
In prokaryotes, an oxidative pathway is responsible for the formation of disulfides and an 
isomerization pathway for the reshuffling of incorrectly formed disulfides (15). DsbA is the 
protein responsible for the oxidation of cysteines to cystine in the periplasm. The strongly 
oxidizing enzyme forms disulfides between any two cysteines that happen to be close enough to 
each other. This was demonstrated in vitro for ribonuclease A, which contains four non-
sequential disulfide bonds. DsbA (in the presence of DsbB and quinones to provide oxidizing 
equivalents) fully oxidizes ribonuclease A yet the oxidized enzyme is inactive as it contains 
incorrect disulfide bonds and is misfolded (17). Hence, there is a need for a reductive 
isomerization pathway in the periplasm. Its main player is disulfide bond isomerase DsbC. This 
enzyme rapidly reduces disulfides to give the folding protein the opportunity for disulfide 
reshuffling, until the correct structure has been reached. This double mechanism of oxidation and 
reshuffling has been confirmed: Folding of proteins with non-sequential disulfide bonds needs 
both DsbA and DsbC (plus DsbB, DsbD, thioredoxin, quinones, etc. to provide oxidizing and 
reducing equivalents to DsbA and DsbC, respectively). On the other hand, proteins with 
sequential disulfide bonds are correctly formed in the absence of disulfide isomerase DsbC. In 
other words, there is no need for reshuffling of wrong disulfides when the cysteines appear in the 
correct order as the protein is exported to the periplasm (18).  
Studies on in vitro oxidative refolding of protein disulfides have a long history. Already in 
Anfinsen’s seminal paper of 1961 it was conjectured that oxidative refolding is a dynamic 
process involving rapid closing and opening of disulfide bonds to reach the correct pairings by 
“trial and error” (19). Subsequent work on ribonuclease, bovine pancreatic trypsin inhibitor, 
lysozyme and other disulfide-containing proteins amply demonstrated the dynamic nature of 
disulfide bond formation and the temporary rise and fall of incorrect disulfides (recent review in 
(20)). Hence, efficient oxidative refolding in the test tube needs a redox buffer, for example, 
reduced and oxidized glutathione, to speed up disulfide formation and enable disulfide 
reshuffling.  
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FIG. 1. Structure of HcpB.  (a) Crystal structure of HcpB. The four repeat motifs are colored 
differently and the disulfide bridges are shown in red. Note that the assignment of helices A and B to 
repeats 1 to 4 follows the definition of Luthy et al. (11), which differs from the assignment used for 
tetratricopeptide repeats (1). (b) Sequence of HcpB with C-terminal His-tag. The four repeats are colored 
as in panel (a) and aligned for sequence homology. Residues in lower case are not part of helices, black 
residues are not seen in the 3D-structure shown in panel (a). The arrow indicates cleavage after Val34 
during synthesis of pDsbA-HcpB in E. coli (see the text for details). (c) Pattern of sequential disulfide 
bonds (boxes with position of cysteines indicated) and of the cysteine-containing tryptic peptides (dashed 
lines). Numbers indicate the N- and C-terminal residues of the peptides. Peptide 126–144 is produced only 
if Cys124 is reduced, peptide 123–144 only if disulfide Cys124–Cys132 is present. 
 
22     30 52 60 88 96 124  132 
N C 
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The contribution of disulfide bonds to the stability of Hcps and the mechanism of 
disulfide formation in Hcps are unknown. We have chosen HcpB, which includes four disulfides, 
to study the oxidative folding of a repeat protein both in vivo and in vitro. In vivo folding of 
HcpB in the periplasm of E. coli follows the direction of export into the periplasm and needs no 
enzymes for disulfide rearrangement. In the test tube one may envisage two principle modes of 
folding. If the disulfides contribute very significantly to the stability of the repeat motif, that is, if 
the reduced protein is essentially unstructured, incorrect disulfides are expected to arise. If, 
however, the reduced protein exhibits some repeating structural features before disulfides are 
formed, incorrect disulfides should have only a small chance of building up. This we could 
confirm: The first two correct disulfides form at random, followed by the appearance of a major, 
structurally unique intermediate with three disulfide bonds. Final formation of fully oxidized, 
native HcpB is rate-limited by disulfide formation in the N-terminal repeat.  
 
EXPERIMENTAL PROCEDURES 
Buffers and chemicals – Standard buffer: 20 mM sodium phosphate, 100 mM KCl, pH 7.0. 
Redox buffer: standard buffer containing 2 mM GSH and 1 mM GSSG. Periplasmic extraction 
buffer: 50 mM sodium phosphate, 300 mM NaCl, pH 8.0, with 1 mg mL–1 polymyxin B (Sigma). 
Chemicals were of analytical grade or of the best grade available and were used without further 
purification.      
Expression and purification of HcpB – Recombinant HcpB was expressed in E. coli, 
solubilized from inclusion bodies and affinity-purified on Ni-NTA agarose as described (11). The 
protein was desalted and freeze dried and the mass of 16160.5 Da, including the 6-His tag (Fig. 
1b), was confirmed by mass spectrometry. The concentration was determined by UV 
spectroscopy using ε276 = 15080 cm−1 M−1.  
Cloning of DsbA-HcpB – To study HcpB folding in the periplasm of E. coli, the gene 
sequence of HcpB was N-terminally fused with the signal sequence of DsbA. Plasmid pDsbA3 
(21) harbors the DsbA gene under the control of the trc promoter. A unique NheI restriction site 
is located at the end of the DsbA signal sequence and a unique BamHI restriction site at the end 
of the DsbA gene. NheI and BamHI restriction sites were introduced by PCR up- and downstream 
of the HcpB gene using the plasmid pTFT74/HP0336 (11), the forward primer 5’-
AGCGTTTAGCGCTAGC-GCGATGGTAGGGGGTGGAACGGTA-3’ (NheI site underlined) 
and the reverse primer 5’-CGGGATCCTTAGTGGTGGTGGTGGTGGTGGTAG-3’ (BamHI 
site underlined). The resulting PCR fragment of the HcpB gene and the pDsbA3 plasmid were 
each digested with NheI and BamHI. The pDsbA3 plasmid was dephosphorylated with shrimp 
alkaline phosphatase (Roche Diagnostics) to avoid self-ligation. After purification (Qiagen kit) 
the HcpB PCR fragment and the pDsbA3 plasmid were ligated with T4 DNA ligase for 1 h at 
room temperature. E. coli strain XL1-Blue chemically competent cells were transformed with the 
ligation mixture and colonies were grown overnight on LB medium supplemented with 50 µg 
mL–1 ampicillin. Plasmid DNA of individual colonies was isolated by the Qiagen mini prep kit 
from saturated overnight cultures. The final plasmid pDsbA-HcpB features the trc promoter, the 
DsbA signal sequence, the HcpB gene and a C-terminal 5×His-tag. Its sequence was confirmed 
by DNA sequencing.  
 In vivo folding of HcpB – Cells of E.coli MC 1000 (wild type), and mutant strains JCB817 
(MC1000, lambda 102+ DsbA–), JCB819 (MC1000, lambda 102+ DsbB–), FED 126 (MC1000, 
DsbD–) and FED 215 (MC1000, DsbC::mini-Tn10KanR) were transformed with the pDsbA-
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HcpB plasmid and grown overnight at 37 °C. A single colony was picked from each plate and 
grown in 5 mL of 2YT medium overnight (30 °C, 180 rpm agitation). Main cultures (500 mL) 
were grown under the same conditions. When an OD of 0.6 was reached, expression was induced 
by 1 mM IPTG, and the culture was grown for an additional 2 or 6 h. Equal amounts of cells 
(concentrations adjusted by OD measurement) were centrifuged at 4 °C and 5000 rpm for 20 min. 
Pellets were re-suspended in 10 mL of periplasmic extraction buffer, shaken for 1 h at 4 °C and 
centrifuged at 18000 rpm for 30 min. Periplasmic extracts were mixed with sample buffer, boiled 
for 5 minutes at 95 °C and separated by electrophoresis on 15% SDS-PAGE. Western blots were 
prepared with monoclonal mouse anti-tetra-His IgG1 (primary antibody, Qiagen) and goat anti-
mouse IgG conjugated with horse radish peroxidase (secondary antibody, Jackson Immuno 
Research Laboratories, Inc.). Bands were visualized by chemiluminescence (BM 
chemiluminescence POD, Roche Applied Science). 
 In vitro oxidative refolding – HPLC-purified, recombinant HcpB (1 mg mL–1) was treated 
with 5 M GdmCl and 0.1 M DTT in standard buffer for 2 h at room temperature. GdmCl and 
DTT were rapidly removed by passing the reaction mixture through a Hi-trap desalting column 
(Sephadex G-25, Amersham Biosciences), which had been pre-equilibrated in standard buffer. 
The eluate was captured in freshly prepared redox buffer to start oxidative refolding. The final 
concentration of HcpB in the redox buffer was 0.5 mg mL–1. Samples were removed at timed 
intervals and cysteine oxidation was quenched by adding an equal volume of 8% TFA. Samples 
were chromatographed by RP-HPLC on a Vydac C8 analytical column (4.6 mm × 250 mm, 
Nucleosil 300-5). The column was eluted with a linear gradient from 46% to 54% B in A at a 
flow rate of 0.7 mL min–1. (A is 3% acetonitrile, 0.1% TFA in water; B is 80% acetonitrile, 
0.085% TFA in water.) Peaks were collected, lyophilized and stored at –20 °C for further 
analysis.  
 Trapping of intermediates by cyanylation – Lyophilized fractions from HPLC-separation 
(0.5 mg mL–1) were cyanylated with 0.2 M freshly prepared CDAP in 100 mM sodium citrate 
buffer, pH 3.0, for 20-30 min at room temperature. CDAP was present in at least 20 fold molar 
excess over free cysteines. Cyanylated material was immediately re-chromatographed by RP-
HPLC to remove the reagent and to re-purify the cyanylated protein fractions. Cyanylation did 
not markedly change the retention time in RP-HPLC.  
Tryptic digestion – Cyanylated HcpB was digested with trypsin (trypsin/HcpB ratio 1:100) 
in 20 mM Tris-HCl, 50 mM NaCl, pH 7.5 for 16 hours at room temperature. The digestion 
mixture was mass-analyzed by MALDI-TOF. 
Major intermediate HcpB3SS and truncated HcpB∆1 – HcpB3SS purified by RP-HPLC was 
kept in argon-saturated standard buffer for use in CD spectroscopy and urea unfolding studies. 
The concentration was determined from ε276 = 15080 cm−1 M−1. HcpB∆1 was prepared from in 
vivo synthesis. To this end, E.coli MC 1000 cells that had been transformed with pDsbA-HcpB 
were grown overnight at 30 °C after induction with 1 mM IPTG. The periplasmic extract was 
prepared as described above and purified by Ni-NTA chromatography followed by RP-HPLC 
fractionation. The peak corresponding to HcpB∆1 was identified by ESI-MS and automated 
Edman degradation, and the concentration was calculated from ε276 = 12035 cm−1 M−1.  
Urea unfolding – Unfolding by urea was followed by the change of the CD signal at 222 
nm. Spectra were taken after overnight incubation of the protein at the desired urea concentration. 
In the case of intermediate HcpB3SS, cysteine oxidation was prevented by keeping all solutions 
saturated with argon. The integrity of HcpB3SS after urea unfolding was confirmed by RP-HPLC 
and ESI-MS. Urea unfolding data were analyzed according to [θ] = (KU/(1 + KU))([θU] – [θF]) + 
[θF], where KU is the unfolding constant defined as fU/(1 – fU) (fU = fraction of unfolded protein), 
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[θ] is the molar ellipticity per residue at 222 nm, and [θF] and [θU] are the molar ellipticity per 
residue of folded and unfolded protein, respectively, assumed to be linear functions of [urea] of 
the form [θi] = [θi,0] + αi[urea]. The free energy of unfolding in the absence of urea, ∆GUW, was 
extrapolated from ∆GU = ∆GUW – m[urea], where ∆GU = –RTlnKU. 
Instrumentation – ESI-MS was performed on a QTOF Ultima API (Waters) instrument in 
0.2% formic acid, 50% acetonitrile at a flow rate of 0.8 µL min–1. MALDI-TOF analysis was 
performed on a Biflex III (Bruker) instrument, using the α-cyano-4-hydroxy cinnamic acid matrix. 
CD spectra were measured on a J-715 spectropolarimeter (Jasco) equipped with a temperature-
controlled water bath.  
 
RESULTS 
 In vivo folding of HcpB produces no wrong disulfides – Folding was studied in the 
periplasm of E. coli. The HP0336 open reading frame for HcpB in the genome sequence of H. 
pylori strain 26695 has no leader sequence for export into the periplasm (22). Therefore, HcpB 
was N-terminally fused with the export signal sequence of DsbA. The pDsbA-HcpB construct, 
which also contained a C-terminal His-tag, was well expressed in wild type E. coli strain 
MC1000 (Fig. 2). The strain has the full set of enzymes necessary to oxidize cysteines (DsbA and 
DsbB) and to isomerize disulfides (DsbC and DsbD). HcpB is expressed to a similar degree in 
the mutant strains lacking either disulfide isomerase DsbC or the partner enzyme DsbD that 
keeps DsbC reduced. In contrast, no HcpB is found in mutant cells lacking either the oxidizing 
enzyme DsbA or the partner enzyme DsbB that keeps DsbA oxidized. This finding demonstrates 
very clearly that oxidative folding of HcpB in the periplasm of E. coli does not pass through 
incorrect disulfides before reaching its native structure.  
 
2 h 
 
6 h 
  
FIG. 2. Western blots of periplasmic extracts from the synthesis of HcpB in E. coli. (Top) Extracts 
from cells induced by IPTG for 2 h. Lane 1, negative control (exported Semliki forest virus protein 
containing no disulfide and no His-tag); lane 2, wild type; lane 3, DsbA– ; lane 4, DsbB– ; lane 5, DsbC– ; 
lane 6, DsbD– ; lane 7, positive control (purified HcpB, overloaded). (Bottom) Extracts from cells 
induced by IPTG for 6 h. Lane 1, positive control; lane 2, wild type; lane 3, DsbA– ; lane 4, DsbB– ; lane 
5, DsbC– ; lane 6, DsbD–. 
When cells were induced for 6 h, a second, faster moving band appeared (Fig. 2 lower 
panel). Both bands were purified by Ni-NTA affinity chromatography. The mass of the upper 
band and its N-terminal sequence correspond to full length HcpB with a mass2 of 16023 kDa and 
an N-terminal sequence of MVGGGT. The lower band has a mass of 12305 kDa and starts with 
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the sequence SNSQIN. Thus, the second band is a truncated form of HcpB lacking residues 1–34. 
It is named HcpB∆1 to indicate the missing first repeat (Fig. 1). Truncation most likely resulted 
from proteolysis in the periplasm. In support, essentially the same truncated product is produced 
when native HcpB is digested with thermolysine for up to 1 h at pH 7 and 25 °C. Thermolysine 
cleaves the native protein exclusively after Ser32 and leaves a folded intact protein with the 
sequence 33–144, which is virtually identical to HcpB∆1 formed under prolonged in vivo folding 
in E. coli (not shown).    
 In vitro oxidative refolding of HcpB follows a sequential pathway with a dominant three-
disulfide intermediate – In principle, disulfide formation can be detected by rapidly and 
irreversibly blocking and identifying the free thiol groups remaining at different time points after 
the start of the folding reaction. Acidification is another means of quenching disulfide bond 
formation since disulfide formation occurs through the deprotonated thiol group. We have 
combined acidification with chemical blocking to follow the in vitro folding pathway of HcpB. 
Sulfhydryl groups were blocked by cyanylation with 1-cyano-4-dimethylamino-
pyridiniumtetrafluoroborate (CDAP) (23). Summarized briefly, the procedure was as follows: 
Fully reduced and chemically denatured HcpB was rapidly transferred into glutathione redox 
buffer at pH 7.0. Refolding was allowed to proceed at ambient temperature. Samples were taken 
at timed intervals, disulfide formation was quenched with TFA and samples were analyzed by 
RP-HPLC under acidic conditions to prevent further oxidation. Chromatographic peaks were 
collected and cyanylated with CDAP at pH 3 to block sulfhydryl groups. Finally, the cyanylated 
products were digested with trypsin and the digestion products identified by MALDI-TOF.  
 Oxidative refolding was started by a rapid buffer change (~15 s) on a short desalting 
column. Folding started immediately as indicated by the rapid drop of the CD signal at 222 nm. 
About half of the native CD signal at 222 nm was reached after 30 s (not shown). Appearance of 
oxidized protein took considerably longer. Fig. 3 shows the time course of disappearance of 
reduced HcpB and appearance of oxidized HcpB during refolding in glutathione buffer. Table 1 
shows the mass analysis of the chromatographic peaks of Fig. 3. Reduced protein (R) dominates 
during the first few minutes. Minor intermediates HcpB1SS and HcpB2SS appear shortly after the 
start of the folding reaction and are gone when the major intermediate HcpB3SS peaks. Oxidized 
protein (N) starts to appear after about 1 h. Mass analysis shows that HcpB1SS, HcpB2SS and 
HcpB3SS contain 1, 2 and 3 disulfides, respectively (Table I). To identify the location of the 
disulfide bonds of the intermediates, the peaks labeled HcpB1SS, HcpB2SS, HcpB3SS, R and N 
were cyanylated and digested with trypsin. Tryptic peptides with cysteine residues were 
identified by MALDI-TOF to obtain the results shown in Table II. Peak N contains only peptides 
with intact disulfide bonds, that is, no cyanylated thiol groups. Peak R contains all the cyanylated 
peptides, that is, no disulfides. Peaks HcpB1SS and HcpB2SS are mixtures of all the cyanylated and 
non-cyanylated tryptic peptides. This means that, at the start of the oxidative folding reaction, a 
correct disulfide can form in any of the four repeats. In contrast, peak HcpB3SS is a unique 
species. Its digestion by trypsin produces oxidized (non-cyanylated) peptides from repeats 2, 3 
and 4, and one reduced (cyanylated) peptide from the first repeat. Most important, no other 
cyanylated or non-cyanylated peptides were found. Incidentally, the non-cysteine containing 
tryptic peptides could also be identified by mass analysis (not shown).  
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FIG. 3. Oxidative refolding of HcpB in glutathione buffer at pH 7.0 and room temperature. (Top) Separation 
of reaction products by RP-HPLC after different times of refolding. R and N are the fully reduced and fully 
oxidized proteins, respectively. Minor peaks to the left and right of N have the same mass as N; the minor peak 
preceding HcpB3SS has the same mass as HcpB3SS; the shoulder preceding R has the same mass as R; the minor 
peak following HcpB3SS in the 1.5 h and 3 h traces is a molecular mixture that could not be resolved. (Bottom) 
Disappearance of reduced protein R (●), appearance of the major intermediate HcpB3SS (*) and of the oxidized 
protein N (▲).  
 
Fully reduced HcpB is partially folded – If the fully reduced protein had a random 
structure, one would expect non-native disulfide bonds to transiently arise during oxidative 
refolding. As this was not seen, the fully reduced protein may already be partially structured. This 
is confirmed by the CD spectrum shown in Fig. 4. The helix content of HcpB measured in the 
presence of 15 mM DTT is about 50% of that of native HcpB. Thus, the reduced protein contains 
significant regular structure. The main folding intermediate, HcpB3SS, has about 85–90% of the 
helix content of native HcpB (dotted spectrum in Fig. 4). This agrees with its presumed structure: 
repeats 2, 3 and 4 folded and oxidized, repeat 1 reduced and unfolded. The three repeats of the 
truncated protein HcpB∆1 are likely to be folded as in the native protein since HcpB∆1 and native 
HcpB exhibit strongly overlapping spectra (Fig. 4).  
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TABLE I 
Mass (Da) of reaction products of oxidative refolding 
separated by RP-HPLC as shown in Fig. 3 
peak in Fig. 3 
mass a 
(calculated) 
 
cyanylated 
thiol groups / 
disulfides 
 
R 
 
16368.2 
(16368.6) 8/0 
 
HcpB1SS 
 
16316.3 
(16316.6) 6/1 
 
HcpB2SS 
 
16264.3 
(16264.6) 4/2 
 
HcpB3SS 
 
16212.0 
(16212.5) 2/3 
 
N 
 
16160.5 
(16160.5) 0/4 
a Masses shown are the average masses calculated by 
the program MaxEnt1 (Micromass U.K.). The mass 
difference between a disulfide (cystine) and two 
cyanylated cysteines is 52. 
 
The first repeat contributes most to the stability of HcpB – Values of ∆GUW, the free 
energies of unfolding in standard buffer at pH 7 and 20 °C, were estimated from reversible 
unfolding by urea. The results are shown in Fig. 5. In terms of the midpoint urea concentration of 
unfolding ([urea]50, see the legend to Fig. 5), native HcpB is the most stable species, fully 
reduced HcpB is the least stable, and the stabilities of HcpB∆1 and HcpB3SS are in between. Free 
energies of unfolding were evaluated by the linear extrapolation method (24) assuming a simple 
two-state folding model. This was justified for native HcpB and truncated HcpB∆1, which unfold 
cooperatively (m-values ~7 kJ mol–1 M–1). Unfolding of the major intermediate HcpB3SS was less 
cooperative (m-value 3.8 kJ mol–1 M–1) and may pass through more than a single transition. 
Therefore, the value of ∆GUW from linear extrapolation has to be considered as a rough 
approximation. The unfolding curve of reduced HcpB was not evaluated since it showed no 
plateau at low urea concentration.  
The major intermediate HcpB3SS and the truncated protein HcpB∆1 are about half as stable 
as native HcpB: ∆GUW = 11 – 14 kJ mol–1 for HcpB3SS and HcpB∆1 versus ∆GUW = 27 kJ mol–1 
for intact HcpB. When compared to fully reduced HcpB, the molar ellipticity of the folding 
intermediate HcpB3SS amounts to about ¾ of the molar ellipticity of native HcpB (Fig. 4). Hence, 
reduced repeat 1 of HcpB3SS is probably unstructured and it is the rate-limiting folding of the first 
repeat that contributes very strongly to the overall stability of native HcpB. We also note that in 
the absence of oxygen, the major intermediate with its unfolded repeat 1 is stable for days (argon-
saturated standard buffer, pH 7, 25 °C). Therefore, the folding of repeat 1 is strongly coupled to 
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cysteine oxidation. Put differently, it is not the folding per se but the formation of the disulfide 
bridge of repeat 1 that contributes very strongly to the stability of the native protein.  
 
TABLE II 
Mass a (Da) of cysteine containing peptides obtained by tryptic digestion of peaks in the 
RP-HPLC profile of oxidative refolding (Fig. 3) 
peptide 
[cyteines] 
(calculated mass) 
Nb Rb HcpB1SSb HcpB2SSb HcpB3SSb 
 
21–41 
[C22, C30] 
(2298.1) 
 
2297.9 (0) 2349.8 (2) 2297.6 (0) 2349.7 (2) 
2297.5 (0) 
2349.7 (2) 2349.8 (2) 
51–61 
[C52, C60] 
(1121.5) 
 
1121.5 (0) 1173.4 (2) 1121.2 (0) 1172.3 (2) 
1121.1 (0) 
1172.2 (2) 1121.4 (0) 
87-102 
[C88, C96] 
(1680.8) 
 
1680.8 (0) 1732.7 (2) 1680.5 (0) 1732.5 (2) 
1680.4 (0) 
1732.4 (2) 1680.6 (0) 
123–144 
[C124, C132] 
(2537.1) 
 
2537.0 (0)  2536.7 (0) 2536.7 (0) 2536.7 (0) 
126–144c 
[C132] 
(2191.0) 
 
 2215.8 (1) 2215.6 (1) 2215.4 (1)  
a Monoisotopic masses of singly charged peptides, i.e. [M + H]+; the mass difference 
between a disulfide (cystine) and two cyanylated cysteines is 52. b Number of cyanylated 
thiol groups in parenthesis; c The C-terminal fourth repeat yielded two cysteine-containing 
tryptic peptides; peptide 123–144 was produced only when the disulfide Cys124–Cys132 
was intact and peptides 123–125 and 126–144 only when the disulfide was reduced; 
peptide 123–125 was not determined. 
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FIG. 4.  CD spectra of HcpB and its derivatives measured at pH 7 and 20 °C. Thick solid line: native 
HcpB. Thin solid line: HcpB∆1 lacking the first repeat motif. Dotted line: major folding intermediate 
HcpB3SS. Dashed line: fully reduced HcpB in the presence of 15 mM DTT.  
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FIG. 5. Urea unfolding curves measured at pH 7 and 25 °C. Solid lines are best fits for two-state 
unfolding for: native HcpB (●), ∆GUW = 27.3 kJ mol–1, m = 7.3 kJ mol–1 M; truncated HcpB∆1 (○), ∆GUW 
= 14.0 kJ mol–1, m = 6.1 kJ mol–1 M–1; major intermediate HcpB3SS (□), ∆GUW = 11.3 kJ mol–1, m = 3.8 
kJ mol–1 M–1. Errors of ∆GUW are estimated at ±3 kJ mol–1. Unfolding of fully reduced HcpB (■) at 5 °C 
could not be analyzed as a two-state transition.   
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DISCUSSION 
 Folding of HcpB in the periplasm of E. coli – Two enzyme systems are necessary for the 
correct oxidative folding of disulfide-containing proteins in the prokaryotic cell (15). The 
DsbA/DsbB system oxidizes cysteines as they appear in the periplasm. If disulfide bonds are not 
consecutive in the amino acid sequence, non-native or incorrect disulfide bonds may form by the 
action of DsbA/DsbB. To produce the native disulfide pattern, the DsbC/DsbD system reduces 
disulfide bonds for re-oxidation by DsbA/DsbB. Direct experimental support of the different 
tasks assigned to the oxidizing and reshuffling enzyme systems was published very recently. 
Correct folding of non-consecutive disulfide bonds in the E. coli periplasmic protein phytase 
needs both enzymatic systems, while mutant phytase with consecutive disulfide bonds folds in 
the presence of the DsbA/DsbB system alone (18). This finding of Beckwith and coworkers is 
now confirmed in a most straightforward way by our results: The formation of disulfide bonds 
located in four repeat motifs arranged in tandem needs no disulfide reshuffling and depends 
solely on the DsbA/DsbB system. To obtain this result, HcpB had to be equipped with a leader 
sequence to be secreted out of the cell. Incidentally, all other Hcps except HcpB carry an N-
terminal export signal, but some Hcps, for example HcpA, were found to also be expressed in the 
cytoplasm despite containing an export signal (10).  
Oxidative refolding of HcpB in the test tube – A vast body of work on in vitro folding of 
protein disulfides has accumulated over the years (20). Typically, non-native disulfides are found 
in many refolding pathways and efficient folding in the test tube needs a redox catalyst to help 
reshuffling of wrongly formed disulfides. Some folding pathways seem to depend on reaction 
conditions, and occasionally even on how the folding intermediates are being trapped (20). One 
feature is rather common: formation of the last disulfide bond often is rate-limiting, the 
conformation of the rate-limiting intermediate being close to the native state (20).  
The oxidative refolding of HcpB is a rather simple process. First, intermediates appear 
with correct disulfide bonds in one or two of any of the four repeats. Thereafter, the unique three-
disulfide species HcpB3SS builds up as the major folding intermediate to finally be transformed 
into the native protein in a rate-limiting step. Obviously, the last oxidation reaction HcpB3SS → 
HcpB has a high transition energy barrier. Based on its CD spectrum, the first repeat of the major 
intermediate HcpB3SS is essentially unstructured. Moreover, the disulfide bond of the first repeat 
is completely buried in the folded protein. Taken together, this may explain why folding of the 
first repeat has a particularly high energy barrier.  
But why should the first repeat contribute almost as much to stability as repeats 2, 3 and 4 
together? There is a peculiarity to HcpB. Most Hcps consist of an odd number of helices where 
the first N-terminal helix acts as a capping structure to protect the hydrophobic core of the protein 
from the solvent. Not so in HcpB. Here the first repeat by itself acts as a capping motif. This may 
explain the higher stability contribution of the first repeat. As a capping structure it protects the 
core of the molecule from the aqueous environment, thereby adding much to stability.  
There is another irregularity to repeat 1. The geometry of the contact between repeats 1 
and 2 differs significantly from the other inter-repeat contacts, as shown in Fig. 6. In the figure, 
interactions between helix B of one repeat and helix A of the following repeat (indicated as 
helices A* in Fig. 6) are being compared. Interactions between repeats 2 and 3 and between 
repeats 3 and 4 are strong and super-imposable. The corresponding interaction between helix B of 
repeat 1 and helix A* of repeat 2 differs significantly. An altered geometry between the first two 
repeats may have to do with the capping function of the first repeat and may also explain the 
limited proteolysis of a single peptide bond in helix 1B producing truncated HcpB∆1.  
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FIG. 6. Superposition of helices A, B and A* of HcpB, where A* is helix A of the next repeat. Note 
that interaction of helix 1B of the first repeat (indicated as yellow helix B) with helix 2A of the second 
repeat (indicated as blue helix 2A*) differs from the other inter-repeat interactions. When comparing 
single repeats, helices A and B are super-imposable. The superposition was calculated based on the 
coordinates of helices A and B of each repeat and neglecting the coordinates of helix A* of the 
subsequent repeat. Color code is as in Fig. 1a. 
 
Oxidative refolding in vitro of HcpB proceeds without apparent reshuffling of non-native 
disulfide bonds. If there are “wrong” intermediates, which we cannot strictly rule out, these are 
very minor species escaping detection under our experimental conditions. Absence of incorrect 
disulfide bonds indicates that some partial repeat structure forms already before cysteine 
oxidation begins. Since, as outlined above, repeat 1 is essentially unfolded before cysteine-
oxidation, early structuring of repeats 2, 3 and 4 seems to prevent wrong cysteine pairings by 
keeping non-consecutive cysteines separated. Helix structure appears immediately after rapidly 
removing GdmCl and DTT from reduced and unfolded HcpB. Fully reduced HcpB in the absence 
of chemical denaturant has approximately 50% of the helix content of the native protein (Fig. 4), 
in agreement with a 41% helix content calculated for the sequence of HcpB (25). Thus, one may 
envisage formation of the stable folding intermediate HcpB3SS as an inherent consequence of 
early structure formation within three of the four repeats. That the N-terminal repeat 1 does not 
fold before cysteine oxidation may be due to its peculiar structure vis-à-vis the remaining part of 
the molecule.   
Conclusion – We found a rather simple in vitro mechanism of disulfide formation in a 
repeat protein featuring one disulfide bond in each repeat. Disulfide formation in the N-terminal 
repeat motif, which contributes most to the overall stability, is the rate-limiting step and proceeds 
from a stable folding intermediate in which three disulfides have been correctly formed. There is 
no obvious formation of non-native disulfides. Oxidative folding of HcpB in the periplasm of E. 
coli substantiates the compensatory roles played by the DsbA/DsbB and DsbC/DsbD systems in 
the folding of disulfide containing proteins in prokaryotes.  
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1 The abbreviations used are: CD, circular dichroism; CDAP, 1-cyano-4-dimethylamino-
pyridiniumtetrafluoroborate; DTT, dithiothreitol; ESI-MS, electrospray ionization mass 
spectrometry; GdmCl, guanidinium chloride; GSH and GSSG, reduced and oxidized glutathione, 
respectively; Hcp, Helicobacter pylori cysteine-rich protein; HcpB, HP0336 gene product of the 
Hcp family; HcpB1SS, HcpB2SS, HcpB3SS, folding intermediates with 1, 2 and 3 disulfide bonds, 
respectively; HcpB∆1, truncated HcpB lacking the first repeat motif; IPTG, isopropyl-β-D-
thiogalactopyranoside; MALDI-TOF, matrix assisted laser desorption/ionization – time of flight 
mass spectrometry; MRE, mean ellipticity per mole of residue; Ni-NTA, nickel-nitrilotriacetic 
acid; RP-HPLC, reverse phase high performance liquid chromatography; TFA, trifluoroacetic 
acid  
 
2 HcpB expressed from pDsbA-HcpB in E. coli contains a 5-His tag, hence the mass difference 
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3.6 Additional experiments on the folding and stability of HcpB  
In this section I describe experiments on the time course of the reductive unfolding of native 
HcpB (section 3.6.1) and on the thermodynamic stability of HcpB and its derivatives followed by 
thermal melting and denaturant unfolding (sections 3.6.2 – 3.6.5). 
3.6.1 Reductive unfolding of HcpB in vitro 
Reductive unfolding (opening of disulfide bonds) of HcpB was monitored in vitro at neutral pH 
(Scheme 3.2). The protein unfolds via the major intermediate (HcpB3SS) which has reduced 
cysteines in the first repeat and oxidized, natively linked disulfide bridges in the other three 
repeats. Interestingly, this major intermediate is the same species that forms during oxidative 
refolding of HcpB (see Fig. 3 and Table I in section 3.5). The time course of reductive unfolding 
of HcpB monitored by RP-HPLC is shown in figure 3.6. 
Native HcpB (0.5 mg/mL) in 20 mM sodium phosphate, 
100 mM KCl, pH 7.0 
↓ 
Add 15 mM DTT (final concentration) 
↓ 
Aliquots removed at regular time intervals and reaction  
quenched by one volume of 8% TFA 
↓ 
Quenched aliquots chromatographed  
by RP-HPLC and lyophilized 
↓ 
Lyophilized fractions (0.5 mg/mL) cyanylated by 0.2 M CDAP  
at acidic pH for 30 minutes 
↓ 
Cyanylated material rechromatographed by RP-HPLC  
and collected peaks split in two aliquots 
↓ 
One aliquot subjected to mass spectrometry, the other to tryptic digestion 
followed by MALDI-TOF (overnight incubation at HcpB/enzyme = 100/1; 20 
mM Tris-HCl, 50 mM NaCl, pH 7.5) 
Scheme 3.2. Experimental details of reductive unfolding of native HcpB. 
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Figure 3.6. Time course of reductive unfolding of HcpB. HPLC-traces of aliqouts removed 
after quenching by TFA at different time intervals are shown. Peaks N (native), HcpB3SS and R 
(reduced) were collected for analysis. Minor peaks to the left and right of N have the same mass 
as N; the shoulder preceding R has the same mass as R, and the shoulder preceding HcpB3SS has 
the same mass as HcpB3SS.    
 
Masses of the cyanylated peaks N, R and HcpB3SS and of the peptides after tryptic digestion are 
exactly the same as those observed during oxidative refolding described in the manuscript in 
Section 3.5. It is difficult to explain why the same major intermediate was seen during reductive 
unfolding. One might speculate that HcpB3SS forms first because the first disulfide bond is most 
easily accessible to the reductant DTT. This is not confirmed by the crystal structure of HcpB in 
which the first disulfide bond is completely buried (0% solvent exposed). As both oxidative 
refolding and reductive unfolding of HcpB produce the same major intermediate, one may 
explain the major intermediate HcpB3SS by an opened/closed equilibrium of the first repeat. 
Opening would be first in unfolding and last in folding. However, we are aware that this is a 
strenuous argument.  
 
3.6.2 Thermal melting monitored by CD spectroscopy  
Temperature-induced unfolding curves of native HcpB recorded by circular dichroism 
spectroscopy are shown in Fig. 3.7. Thermal unfolding of HcpB is reversible to only ~60% at pH 
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>5.5. For that reason the stability of HcpB at neutral pH can not be reliably estimated from 
thermal melting experiments. At lower pH reversibility is higher than 85% and thermal melting 
provides information about ∆Gunf and the unfolding mechanism.  
 
Figure 3.7. Thermal melting curves from CD spectroscopy. Change of MRE222 upon 
continuous heating at 1 deg min−1 at pH 2, 2.4, 3, 3.5, 4 and 5 (left to right). Protein 
concentration was 50 µM. Buffer: 7.5 mM each of boric, citric and phosphoric acid adjusted to 
the desired pH with KOH and to an ionic strength of 100 mM with KCl.  
 
The Tm of the protein is highest at pH 5.0. Below 10 °C and above 70 °C MRE222 is very similar 
between pH 2 and pH 5, indicating that the helical content of the native state and the structure of 
the denatured state are not appreciably influenced by pH. However, the mid-point of thermal 
unfolding shifts by 25 °C between pH 2 and pH 5 (Table 3.2). Hence, acidic pH significantly 
destabilizes the protein.  
3.6.3 Isothermal unfolding with urea 
The stability of HcpB at pH 5.0 was assessed by urea unfolding at different temperatures 
following the change of the CD minimum at 222 nm (Fig. 3.8). All transitions were fully 
reversible and the protein remained fully oxidized throughout unfolding. Interestingly, we 
observed a significant decrease in ellipticity at high urea concentrations and increasing 
temperature, indicating temperature-induced structural variation of the urea-denatured state. 
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Another peculiarity of the unfolding curves is that MRE222 decreases slightly but reproducibly 
between 0 and 0.5 M urea. This effect is possibly caused by small structural rearrangements due 
to protein-urea interactions.  
 
Figure 3.8. Urea-induced unfolding of HcpB. Mean ellipticity per residue at 222 nm (MRE222) 
of HcpB (20 µM) was measured as a function of increasing urea concentrations at pH 5 and 5 °C 
(closed circles), 15 °C (triangles), 25 °C (squares) and 40 °C (open circles). Solid lines are best 
non-linear fits.  
 
The non-linearity at low urea concentration was neglected and the data were modeled by a two-
state transition between native and unfolded protein. The linear extrapolation procedure was used 
to  calculate the Gibbs free energy of unfolding, ∆Gunf, at zero urea (Table 3.1). The [urea]0.5 and 
m-values were very similar up to 25 °C and decreased at higher temperatures. The variation of 
∆Gunf (~29 kJ mol−1) between 5 and 25 °C is lower than the experimental error. Significant 
destabilization occurs at 40 °C (∆Gunf = 19.6 kJ mol−1).  
3.6.4 Thermal melting monitored by differential scanning calorimetry (DSC) 
Thermal melting at pH 2, 3, 4 and 5 was also followed by DSC (Fig. 3.9). The partial specific 
heat capacity at 25 °C is close to the values measured for typical globular proteins but exhibits a 
steeper increase with temperature: 8.5×10−3 J g−1 K−2 at pH 5 to 13.8 ×10−3 J g−1 K−2 at  pH 2, as 
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compared to the reference value of (6.7 ± 1)×10−3 J g−1 K−2 [32]. The transitions are relatively 
broad, especially at low pH.  
 
Figure 3.9. DSC traces from pH 2 to pH 5 (left to right). The change of the molar heat 
capacity upon continuous heating at 1 deg min−1 is shown. Protein concentration was 150 µM. 
The first heating was stopped when the protein was unfolded > 95% (continuous black lines). 
After cooling, the heating was repeated to higher temperatures to collect data on the heat 
capacity of the unfolded protein by dotted lines (red). The predicted heat capacity for complete 
unfolding is represented by the dashed line (blue). The heat capacity of a typical globular domain 
of the size of HcpB is shown by the dash-dotted line (green).  
 
The heat capacity of the denatured state is lower than the predicted heat capacity of a fully 
solvated polypeptide chain with the amino acid composition of HcpB. The apparent heat capacity 
increment in the melting zone is ∆Cp = is 4 ± 0.3 kJ K−1 mol−1 (mean from four DSC traces). 
Kirchoff plots of ∆Hm vs. Tm were used to obtain ∆CP (in units of kJ K−1 mol−1). Values of ∆CP 
were calculated from three different sets of enthalpy values:  ∆CP = 7.3 ± 1.1 from calmH∆  
(calorimetric, model-independent enthalpy), ∆CP = 4.6 ± 0.7 from DSC,vHmH∆  (van’t Hoff enthalpy 
from DSC), ∆CP = 4.9 ± 1.5 from CD,vHmH∆  (enthalpy from CD melting). 
It has been argued that the most reliable estimate for the unfolding enthalpy is the weighted 
average of calmH∆ and DSC,vHmH∆ , which is calculated as WAH∆ = 0.35× calmH∆  + 0.65 × DSC,vHmH∆  
[33].  ∆Cp calculated from the plot of ∆HWA vs. Tm is 5.6 ± 0.1 kJ K−1 mol−1. All these estimates 
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are considerably lower than ∆Cp = 8–9 kJ K−1 mol−1 expected for a 16 kDa protein obeying the 
“ideal” unfolding behavior [34].  
 
Table 3.1: ∆Gunf  and m values from urea unfolding curves at 
pH 5 obtained at different temperatures. Errors of ∆Gunf and m 
are estimated as 3 kJ mol–1 and 0.8 kJ mol–1 M–1, respectively. 
T (°C) [Urea]0.5 (M) ∆Gunf (kJ mol–1) m (kJ mol–1 M–
1) 
5 3.8 28.7 7.8 
15 3.8 28.9 7.2 
25 3.7 28.8 7.0 
40 3.4 19.6 6.4 
 
We conclude that at the on-set of the main unfolding event, HcpB is significantly hydrated and/or 
quite flexible in comparison to the low-temperature folded state. This follows also from the per-
residue unfolding enthalpy (2.1 kJ mol res−1) and entropy (6.3 J K−1 mol res−1) calculated at 65 
°C, which both are among the lowest values that have been measured for proteins [34]. 
According to the DSC data, the main unfolding transition of HcpB is rather cooperative between 
pH 3 and 5, as judged by the ratio of the model-independent calorimetric to the model-dependent 
van’t Hoff enthalpy, calm
DSC,vH
m HH ∆∆ , which is close to unity (Table 3.2). At pH 2, 
cal
m
DSC,vH
m HH ∆∆ is close to two. Since melting is perfectly reversible at pH 2 and the protein is 
monomeric, the reason for the ratio of 2 is not clear. However, the fraction of unfolded protein, fU, 
changes in a non-parallel fashion with temperature when calculated from CD or DSC data (Fig. 
3.10).  
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Table 3.2: Thermodynamic parameters describing the thermal melting of HcpB by CD and 
DSC studies at different pH.  
pH Tm (°C) 
CD 
Tm (°C) 
DSC 
∆HmvH (kJ mol–1)
DSC 
∆Hmcal (kJ mol–1) 
DSC 
∆HmvH/∆Hmcal 
2 39.3 40.4 182 94 1.93 
2.4 45.2     
3 51.7 53.3 216 225 0.96 
3.5 58.7     
4 61.6 64.4 283 287 0.98 
5 64.8 66.3 304 280 1.08 
 
The temperature of 50% unfolding (fU = 0.5) is systematically higher in the DSC experiment. It is 
likely, therefore, that melting of the secondary structure precedes the disruption of gross packing 
interactions. A further indication that unfolding of HcpB deviates from the two-state model 
comes from a global analysis of the data according to the Gibbs-Helmholtz equation. The 
unfolding free energy measured at different temperatures can be combined with ∆Gunf = 0 at the 
mid-point of the thermal unfolding transition, Tm, to calculate the unfolding enthalpy at Tm and 
∆Cp. At pH 5, a best fit was obtained with ∆Cp = 7 ± 0.4 kJ K−1 mol−1. However, the calculated 
enthalpy was 400 kJ mol−1 (pH 5), in significant disagreement with the enthalpy obtained from 
the analysis of individual thermal melting experiments. Urea-induced unfolding predicts a higher 
stability than thermal melting.  
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Figure 3.10. Fraction of unfolded HcpB as a function of temperature at pH 2, 3, 4, and 5 
(continuous lines, left to right, calculation based on the data of Fig 3.7). Dashed lines represent 
fraction unfolded HcpB calculated from the DSC data of Fig. 3.9. 
 
In conclusion, unfolding of native HcpB deviates from a two-state model and involves 
intermediates. The temperature-induced denatured state of HcpB is only partially hydrated, which 
could be due to disulfide bridges keeping the repeating motifs partially intact. During unfolding 
the helices melt first followed by the global unfolding event. The same we have observed for an 
ankyrin repeat protein [35].  
3.6.5 Contribution of disulfide bridges to stability  
Further to the urea unfolding experiments reported in Fig. 5 of section 3.5, we also performed 
thermal CD melting experiments at pH 7 with native HcpB, disulfide reduced HcpB (HcpBred), 
the major folding intermediate HcpB3SS and the truncated protein HcpB∆1 (Fig. 3.11) to reveal the 
stabilizing role of disulfide bonds.  
The apparent melting temperature of fully reduced HcpB is 39 °C, that of folded HcpB is 61 °C. 
Midpoint temperatures for the major intermediate HcpB3SS and the truncated protein HcpB∆1 are 
similar, about 56 °C. From this follows that the disulfide bridges significantly stabilize HcpB.  
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Figure 3.11. Thermal melting followed by CD at pH 7. MRE222 recorded with 50 µM protein 
at a heating rate of 1 deg min−1. Native HcpB (black), HcpB∆1 (blue), HcpB3SS (green), reduced 
HcpB (red). Buffer: 20 mM sodium phosphate, 100 mM KCl, pH 7.0.  
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4 Different Effects of Urea and Guanidinium Chloride on the Free 
Energy of Unfolding of a Protein 
(An attempt at solving a longstanding problem) 
4.1 Introduction 
The linear extrapolation model (LEM) – The free energy of unfolding of a protein is the 
difference between the free energies of the folded and unfolded states: ∆GU = GU – GF, where GU 
and GF are the absolute free energies of the unfolded and folded state, respectively, and ∆GU is 
the free energy that is necessary to unfold the protein. In other words, ∆GU is a measure of the 
protein’s thermodynamic stability. While the absolute free energies, GU and GF, are not open to 
experiment, there are several ways to determine ∆GU. A popular one is the linear extrapolation 
method, LEM for short (1). It provides an estimate of ∆GU in a very simple, albeit indirect way: 
∆GU is measured in the presence of increasing concentrations of a chemical denaturant, [den], 
and ∆GUW, the free energy of unfolding in plain buffer, is obtained by linear extrapolation to zero 
denaturant concentration according to  
∆GU = ∆GUW – m [den]        (4.1) 
The slope m can be regarded as the “strength of the denaturant effect” on the native 
conformation. Larger the m, the more sensitive the protein to chemical denaturation. Urea and 
GdmCl are the most commonly used denaturants.  
4.1.1 The problem 
To be generally applicable, linear extrapolation should provide the same value of ∆GUW 
independent of the nature of the denaturant. However, for the same protein different ∆GUW-values 
are sometimes extrapolated from urea and GdmCl unfolding data, respectively. In LEM, the 
properties of the folded and denatured state in the transition zone of unfolding, that is, in the 
presence of sometimes high concentrations of denaturant, are projected to zero denaturant 
concentration. If urea and GdmCl alter the thermodynamic character of the folded and denatured 
states in different ways, extrapolation to zero denaturant concentration may not yield the same 
free energy of unfolding. GdmCl, but not urea, acts as a dissociated salt and screens electrostatic 
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interactions. The screening effect of GdmCl is perhaps the most important reason why chemical 
unfolding may occasionally yield inconsistent ∆GUW-values. We know of only a few reports in 
which the effect of urea and GdmCl on both the kinetics and equilibrium thermodynamics of 
protein folding have been compared (2-6).  
We have chosen the dimeric, disulfide-linked leucine zipper ABSS to test how the nature of the 
denaturant influences the magnitude of ∆GUW. In particular, we compare the effect of urea and 
GdmCl on the equilibrium value of ∆GUW calculated according to eq 4.1 and on the value of 
∆GUW deduced from the rates of folding and unfolding according to  
∆GUW = –RTln(kf/ku)       (4.2) 
Here, kf and ku are the first order rate constants of folding and unfolding, respectively. They again 
are obtained by linear extrapolation from values of kf and ku measured in the presence of different 
concentrations of denaturant.  
4.1.2 Previous work on electrostatic effects on the stability of leucine zippers 
Electrostatic interactions between oppositely charged side chains, called “salt bridges”, are 
typical features of proteins. Salt bridges are commonly assumed to stabilize the native protein. 
However, experimental and computational analyses indicate that salt bridges are not necessarily 
stabilizing (7). Leucine zippers (or coiled coils in general) are good models to study electrostatic 
interactions in proteins because they feature salt bridges between adjacent helices, and these can 
easily be manipulated by mutation (8-10). In the simplest case, leucine zippers consist of two α-
helical peptides wound around each other and held together by hydrophobic packing along the 
dimer interface. The amphipathic coiled coil structure originates from a 7-residue sequence motif, 
(abcdefg)n, repeating every two α-helical turns. Hydrophobic residues dominate at positions a 
and d of each heptad while positions e and g are often charged.  
Marti and Bosshard used designed leucine zippers to probe the effect of electrostatic interactions 
to protein stability (11-14). The work described in this Chapter is based on leucine zipper ABSS 
(13). Figure 4.1 shows a helical wheel representation of ABSS, which is composed of an acidic A-
chain and a basic B-chain. The A- and B-chains by themselves are unfolded because of charge-
charge repulsions and because the hydrophobic residues in positions a and d of a single α-helix 
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are exposed to the aqueous environment. When combined, A- and B-chains associate 
spontaneously to a heterodimeric coiled coil, a phenomenon dubbed “peptide Velcro” (8).  
 
Ac-E-VAQLEKE-VAQAEAE-NYQLEQE-VAQLEHE-CG-NH2 
                                 │ 
Ac-E-VAQLKKR-VQALKAR-NYALKQK-VQALRHK-CG-NH2 
 
Figure 4.1 Top: Sequence of the dimeric, disulfide-linked leucine zipper ABSS. Heptad 
repeats are separated; a and d heptad position residues are in bold, g and e heptad position 
residues are in italics. The C-terminal disulfide bridge is indicated by a vertical line. Bottom: 
Helix wheel representation of leucine zipper ABSS. Heptad positions are denoted with lower 
case letters in italics. Solid arrows denote hydrophobic interaction contacts of a and d heptad 
position residues at the chain interface. Dashed arrows denote inter-chain salt bridge formation 
between g and e heptad position residues of chains A (left) and B (right). Figure adapted from 
(14). 
 
In the design of ABSS, the two chains have been linked by a C-terminal disulfide bridge. This 
facilitates both the thermodynamic and the kinetic analysis of the folding/unfolding reaction since 
reactions become concentration-independent if the two chains are disulfide-linked. The 3D 
structure of ABSS, solved by 1H-NMR spectroscopy (13), is shown in Figure 4.2. 
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Figure 4.2 Backbone traces and selected side chain bonds of 48 ABSS NMR structures 
superimposed by fitting backbone atoms to the mean. Acidic residues (Glu) are displayed in 
red and basic residues (Lys, Arg) in blue; backbone bonds are colored green; groups of salt 
bridges are encircled by solid lines and unpaired charges by dashed lines. “Front” and “back” 
views of the molecule are shown. Figure adapted from (13).  
 
The energetic contribution of ionizable Glu and His side chains was evaluated from the residues’ 
pKa values in the folded and unfolded leucine zipper, respectively. The contribution of a single 
charge to the free energy of unfolding of the protein is proportional to the pKa change between 
the folded and unfolded structure (7). Some charges were found to stabilize the folded leucine 
zipper, others were destabilizing.  
4.1.3 Previous work on the effect of urea and GdmCl on leucine zipper ABSS 
The thermodynamic stability of ABSS has been studied over the pH range 2–7 by chemical 
denaturation at constant temperature as well as by thermal unfolding (12). Urea unfolding and 
thermal denaturation yield similar values of ∆GUW. Unfolding by GdmCl, however, yields 
significantly different unfolding parameters. The results are summarized in Figure 4.3 taken from 
(12).  
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Figure 4.3 pH-stability profile of leucine zipper ABSS presented as the change in the free 
energy of unfolding vs. pH. Left: Absolute free energy of unfolding, ∆GUW vs. pH. Right: 
Relative free energy of unfolding ∆∆GUW defined as ∆GUW(pH) – ∆GUW(pH2) vs. pH. Figure 
adapted from (12). 
 
Three features of Figure 4.3 spring to the eye:  
(i) Leucine zipper ABSS is more stable at low pH than at neutral pH, indicating a net 
unfavorable charge effect at neutrality. (The larger ∆GUW, the more stable the native 
protein.) 
(ii) In absolute terms, ABSS is more stable at pH 2 when ∆GUW is extrapolated from 
GdmCl unfolding. The opposite is seen at pH 7: ABSS is more stable when ∆GUW is 
extrapolated from urea unfolding (left panel).  
(iii) The stability difference between pH 2 and pH 7 is larger for GdmCl unfolding than 
for urea and thermal unfolding, ~17 vs. ~5 kJ/mol (right panel).  
Observations (i) – (iii) are clear manifestations of denaturant effects. The experiments to be 
described in this Chapter attempt at explaining these denaturant effects by following the kinetics 
of folding of ABSS at acidic and neutral pH.  
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4.1.4 Relationship between free energies of unfolding and kinetic rate constants 
If GdmCl and urea alter the structures of native and unfolded ABSS in different ways, this will 
lead to denaturant effects on the folding and unfolding rates of ABSS. For example, charge 
screening by GdmCl might reduce unfavorable charge-charge interactions and thereby stabilize 
the folded or the unfolded state of ABSS. Similarly, charge screening might reduce favorable 
charge-charge attraction and thereby reduce protein stability. As a consequence, one expects 
charge screening to also affect the rates of folding and unfolding. Since charge-charge 
interactions are pH-dependent, the kinetic effects of charge screening will be pH-dependent as 
well. From measuring the rates of folding, kf, and unfolding, ku, in the presence of increasing 
amounts of denaturant, the rate constants in the absence of denaturant, kfW and kuW, are linearly 
extrapolated according to:  
lnkf = lnkfW – mf [den]/RT                                   (4.3) 
lnku = lnkuW + mu [den]/RT                                  (4.4) 
The rate constant accessible to experiment is kobs. Since kobs = kf + ku, it follows: 
lnkobs = kfWexp(–mf [den]) + kuWexp(mu [den])     (4.5) 
A plot according to eq 4.5 of lnkobs vs. the denaturant concentration is called a Chevron plot and 
yields values for kf, ku, mf and mu. The slopes mu and mf describe the dependence of the rate 
constant on denaturant concentration. The magnitude of mu and mf is an empirical measure of the 
change in the solvent exposed surface when the protein passes through the transition state 
separating the folded from the unfolded state. Since m of the equilibrium chemical unfolding 
experiment (eq 4.1) is proportional to the overall surface change accompanying the unfolding 
reaction, there follows the relationship: 
m = RT(mf – mu)                                               (4.6) 
To be consistent, equilibrium and kinetic unfolding experiments should yield similar values of 
∆GUW (eqs 4.1 and 4.2) and m (eqs 4.1 and 4.6).   
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4.2 Materials and methods 
Materials – Leucine zipper ABSS was chemically synthesized and purified as described (11). 
GdmCl and urea were of the highest purity available from Fluka. The concentration of ABSS was 
determined by UV absorption in 6 M GdmCl using ε275.3 = 1450 M–1cm–1.   
Buffers – All experiments were conducted in buffer composed of phosphoric, citric and boric 
acid, 7.5 mM each, adjusted to the desired pH with KOH or HCl and to an ionic strength of 0.1 M 
with KCl. The pH of buffers containing urea or GdmCl was adjusted after adding the denaturant. 
The concentration of denaturant was measured by refractometry.  
Stopped-Flow Measurements – Experiments were performed with the help of a π*-180 rapid 
mixing instrument (Applied Photophysics). The instrument had an optical path length of 10 mm 
and a dead time of 1–2 ms. The wavelength of detection was 225 nm and the slits were set to 4 
mm. Ten to 15 firings were averaged for each kinetic trace. Raw data were analyzed with the 
software provided by the manufacturer.  
Experiments with GdmCl – Unfolding of ABSS was followed after 1:10 dilution of ABSS (100 
µM) with GdmCl. For measurements at pH 2, the final concentration of GdmCl was ≥5 M, and at 
pH 7 ≥3 M. Refolding was measured by rapidly mixing of one volume of ABSS (100 µM) in 6 M 
GdmCl (pH 2), or in 4 M GdmCl (pH 7.0), with 10 volumes of buffer containing an appropriate 
concentration of denaturant.   
Experiments with urea – These were performed in the same way as the experiments with 
GdmCl except that for unfolding, the final concentration of urea was ≥7 M at pH 2 and ≥6 M at 
pH 7. For refolding, ABSS was pre-equilibrated with 8 M urea at pH 2 and 8 and rapidly diluted 
1:10 with appropriate concentrations of urea in buffer.  
Error calculation – Standard errors of extrapolated rate constants and m-values were estimated 
by the method of error propagation using data sets truncated by one data point at a time.  
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4.3 Results 
Refolding rate constants were measured by rapid dilution of denaturant unfolded ABSS into 
folding conditions. Unfolding rate constants were obtained in the same way by rapidly diluting 
the folded protein into GdmCl or urea solutions. The reaction was monitored from the change of 
the CD absorption at 222 nm, a CD minimum typical of the folded α-helix structure. The signal 
change could be described by a single exponential rise or decay, in agreement with a 
concentration-independent, mono-molecular reaction. The relaxation time, τ, of the single 
exponential function yields kobs = 1/τ. Chevron plots of the kinetic experiments are shown in 
Figure 4.4. Kinetic parameters extrapolated to zero denaturant concentration with the help of eq 
4.5 are summarized in Table 4.1.  
There is one unique and highly significant difference between the urea and GdmCl data. At pH 2, 
kuW from the GdmCl experiment is three orders of magnitude smaller than kuW from the 
analogous urea experiment. All other rate constants from the GdmCl and urea experiments are 
similar, or even identical within the limits of experimental uncertainty.  
The main difficulty with these experiments was the very high rate of refolding and, in the case of 
urea, the weak dependence of unfolding on urea concentration. When ABSS was diluted into low 
concentrations of denaturant, refolding was completed within the dead time of the instrument. 
Therefore, the extrapolation of the rate constants and m-values had to span over a large area for 
which no experimental data points are available (Fig. 4.4).  
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Figure 4.4 Chevron plots of folding/unfolding of ABSS deduced from rapid dilution into 
GdmCl and out of GdmCl (top), or into urea and out of urea (bottom). Data for pH 2 and 
pH 7 are distinguished by color. Solid lines are best non-linear fits according to eq 4.5. 
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Table 4.1 Kinetic parameters extrapolated from Chevron plots of Figure 4.4 by non-linear 
fitting according to eq. 4.5. The standard error of the extrapolated rate constants and m-values 
is in the range of 20–50%. The only two significantly different rate constants are in bold. 
 GdmCl 
 kfW (s–1) kuW (s–1) mf (M–1) mu (M–1) 
∆GUW a) 
(kJ mol–1) 
pH 2 3.1×104 6×10–3 1.7 –1.4 35.8 
pH 7 2.1×104 7.6 2.7 –0.76 18.2 
 Urea 
 kfW (s–1) kuW (s–1) mf (M–1 ) mu (M–1) 
∆GUW  
(kJ mol–1) 
pH 2 3.0×104 0.5 1.3 –0.30 25.5 
pH 7 2.6×104 6 1.3 –0.25 19.4 
a) ∆GUW = –RT ln (kfW/kuW)   
 
4.4 Discussion 
4.4.1 Limits of the kinetic analysis  
The main difficulty with the kinetic experiments described in this Chapter is in the extremely 
rapid rate of folding of ABSS. Even at moderate denaturant concentrations, the apparent folding 
rate, kobs, was of the order of the reciprocal dead time of the instrument, about 500–1000 s–1. 
Therefore, refolding could not be measured below 4 M urea or below 2–3 M GdmCl (see the 
distribution of the experimental data points in Figure 4.4). Also, unfolding needed high 
denaturant concentrations. Hence, both the folding and unfolding limbs of the experimental 
Chevron plots are rather short. This is a serious weakness of all the kinetic experiments with 
ABSS. It is for this reason that the project was abandoned. Nevertheless, some tentative 
conclusions can be drawn and a plausible explanation for the different effects of GdmCl and urea 
on ABSS unfolding can be given. 
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4.4.2 Effect of denaturant on rates of folding and unfolding 
The following discussion assumes the validity of eqs 4.3 – 4.5, that means, a linear relationship 
between the rates of refolding/unfolding and the denaturant concentration. Thus, any deviation 
from linearity at very low (or very high) denaturant concentration, known as a “roll-over”, is 
excluded. With this limitation in mind, the most conspicuous result is the thousand fold lower 
rate of unfolding at pH 2 deduced from the GdmCl data: kuW = 0.006 s–1 (GdmCl) vs. 7.6 s–1 
(urea). This difference is the main reason why at pH 2, ABSS appears twice as stable in the 
GdmCl experiment than in the urea experiment. Actually, the very different kuW-values at pH 2 
constitute the only significant difference between the GdmCl-deduced and urea-deduced kinetic 
rate constants. This is a remarkable result. It may be interpreted by a significant stabilization of 
folded ABSS at pH 2 through charge screening by GdmCl because a more stably folded ABSS 
structure is expected to unfold more slowly. On the other hand, virtually unchanged rate 
constants at pH 7 extrapolated from the GdmCl and the urea experiment, respectively, indicate no 
significant charge screening by GdmCl at neutral pH. Also the rates of folding at pH 2 and pH 7 
in the absence of denaturant are very similar and apparently independent of the denaturant: kfW ~ 
(2–3)×104 s–1. We believe this is in support of a common folding mechanism and of the validity 
of LEM. Put differently, non-equivalence of kfW-values would indicate differences in the folding 
transition induced by GdmCl and urea, respectively. 
Why does charge screening manifest itself only in different values of kuW at pH 2? In principal, 
charge screening takes effect at any pH and in both the folded and unfolded ABSS. Figure 4.5 
shows a very simplified scheme of charge screening effects on the conformational states of ABSS 
at pH 2 and 7. At neutral pH, folded ABSS features several salt bridges as well as a few unpaired 
charges (Figure 4.1). At pH 2, plus charged side chains of Lys and Arg dominate while Glu side 
chains are protonated (unchared). Hence, charge-effects at pH 2 are repulsive and unfavorable. 
We assume that folded ABSS is stabilized thanks to lesser charge-charge repulsion at pH 2, and 
that this leads to the very slow rate of dissociation of ABSS under acidic conditions. We recognize 
there might be other explanations. For example, GdmCl may strengthen hydrophobic interactions 
in folded ABSS.  
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Figure 4.5 Schematic representations of charge effects in folded and unfolded ABSS at pH 2 
and pH 7, respectively. Charge screening is symbolized by dotted circles around charges. In this 
very simple scheme, only screening of full charges is considered. The only manifest kinetic effect 
of charge screening occurs in the folded protein at pH 2 (red dashed circles) and leads to a 
thousand-fold smaller value of ku (red). 
 
At pH 7 charge screening should weaken interactions between plus and minus charges and lower 
the effect of single charges (Figure 4.5). But GdmCl has no kinetic effect at pH 7. Perhaps access 
of the guanidinium ion to charge-charge pairs and single minus charges is sterically hindered in 
folded ABSS at pH 7.  
4.4.3 Correlation between kinetic and equilibrium parameters 
Table 4.2 compares the kinetic and equilibrium thermodynamic data sets. The correlation is 
satisfactory. Absolute values of ∆GUW from equilibrium and kinetic data differ by as much as 7 
kJ mol–1. Unlike in the equilibrium unfolding experiment, the stability of ABSS at pH 7 is very 
similar from both the GdmCl and urea unfolding data, 18.2 versus 19.4 kJ mol–1. In equilibrium 
unfolding ABSS is much less stable in the GdmCl experiment, 12 kJ mol–1 versus 17.5 kJ mol–1. 
However, the relative changes of ∆GUW between pH 2 and pH 7 are remarkably similar. Thus, the 
change of stability between pH 2 and 7, expressed as ∆∆GUW, is the same within error whether 
determined by equilibrium unfolding experiments or by kinetics: about 17 kJ mol–1 for the 
GdmCl experiment and about 5 kJ mol–1 for the urea experiment. This congruence of the 
equilibrium and kinetic results supports the validity of the linear extrapolation method used to 
analyze the very limited set of kinetic data.  
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Since mu and mf are proportional to the change in the solvent exposed surface when the protein 
passes through the transition state separating the folded from the unfolded state, one can define 
the parameter βTS to indicate the position of the transition state between the folded and the 
unfolded state: βTS = –RTmu/m. The smaller βTS, the more folded is the transition state. Values of 
βTS calculated from the kinetic data are below 0.2, in line with a rather folded transition state. If 
GdmCl has any effect it is to slightly increase βTS, that is, to render the transition state “less 
folded”. However, the effect is small and probably insignificant.  
Table 4.2 Comparison of data from equilibrium unfolding and kinetic experiments 
 Equilibrium data (from ref. (12)) 
 GdmCl urea 
 pH 2 pH 7 pH 2 pH 7 
∆GUW  
(kJ mol–1) 29 12 22.5 17.5 
m  
(kJ mol–1 M–1) 6.6 6.6 3.6 3.6 
 Kinetic data (this work) 
 GdmCl urea 
 pH 2 pH 7 pH 2 pH 7 
∆GUW  
(kJ mol–1) 35.8 18.2 25.5 19.4 
mf (M–1) 1.7 2.7 1.3 1.3 
mu (M–1) –1.4 –0.76 –0.30 –0.25 
m = RT(mf – mu) 
(kJ mol–1 M–1) 7.7 8.6 4.0 3.8 
βTS = –RTmu/m 0.18 0.09 0.08 0.07 
 
4.4.4 Conclusion 
Because of severe experimental limitations a comprehensive analysis of the folding/unfolding 
kinetics of ABSS was not possible. Still, we can tentatively explain the previously observed higher 
stability of ABSS extrapolated from GdmCl unfolding. The rate of unfolding of ABSS at pH 2 is 
slowed by one thousand-fold. This is taken to indicate strong screening by GdmCl of unfavorable 
charge-charge repulsions at pH 2, making folded ABSS significantly more stable at acidic pH.  
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